data_1auu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1auu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 HD13 ' A' ' 12' ' ' ILE . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.613 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' HA ' HG21 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.647 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.456 HG12 HD13 ' B' ' 12' ' ' ILE . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.621 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.443 ' HA ' HG21 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.44 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.529 HG12 HG22 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' B' ' 48' ' ' ILE . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.631 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.529 HG22 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.599 HG23 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.579 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.631 HG13 HD13 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.655 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.49 HG22 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.688 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.563 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.47 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HG3' ' CG2' ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD13 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' A' ' 12' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.563 ' HD2' HG21 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' HD13 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.683 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.446 ' CG2' ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.671 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.561 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.479 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' B' ' 6' ' ' ILE . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' CG2' ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.68 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' B' ' 12' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.576 ' HD2' HG21 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.576 HG21 ' HD2' ' B' ' 32' ' ' LYS . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.488 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.516 ' HA ' HD13 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.68 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.617 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.442 ' CG2' ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.702 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 31.8 t60 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.471 HG12 ' CG2' ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HG13 HG21 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.472 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.412 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 31.6 t60 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.422 HG13 HG21 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.487 ' HG ' ' CG2' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.52 HD11 ' HA3' ' B' ' 25' ' ' GLY . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.483 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.487 ' CG2' ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.643 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.492 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.643 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.561 ' HG3' HG22 ' A' ' 48' ' ' ILE . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.448 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.583 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.457 HG21 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.561 HG22 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.639 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.572 ' HG3' HG22 ' B' ' 48' ' ' ILE . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.51 HD22 HG12 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' B' ' 38' ' ' VAL . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.51 HG12 HD22 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.636 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.455 HG21 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.572 HG22 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 43' ' ' ILE . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.609 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.528 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 ' HB1' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HD21 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' B' ' 47' ' ' PHE . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' HG12 ' A' ' 43' ' ' ILE . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.534 HG13 ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 32' ' ' LYS . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.55 ' HA ' HD11 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 1' ' ' MET . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.551 ' HE2' HD12 ' B' ' 43' ' ' ILE . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.556 ' HA ' HG11 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.521 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.551 ' HB1' HD23 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.616 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.491 ' HB3' HG22 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 47' ' ' PHE . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.501 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.529 ' HD3' HG21 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.529 HG21 ' HD3' ' B' ' 32' ' ' LYS . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.448 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.545 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.551 HD12 ' HE2' ' B' ' 1' ' ' MET . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.619 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.511 ' CE ' HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.672 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.468 ' HA ' HG13 ' A' ' 12' ' ' ILE . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.468 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.672 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 43' ' ' ILE . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' A' ' 43' ' ' ILE . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HD2' HG13 ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.522 ' CE ' HD12 ' B' ' 43' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.498 ' HA ' HG11 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.486 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.666 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.449 ' HA ' HG13 ' B' ' 12' ' ' ILE . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' B' ' 6' ' ' ILE . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.526 HG21 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.529 ' HB3' HG22 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.566 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' B' ' 43' ' ' ILE . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.529 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.566 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.55 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.529 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.487 ' HA ' HD11 ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 33.7 t60 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HE3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' B' ' 47' ' ' PHE . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.477 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.55 ' HA ' HD13 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.542 HG22 ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.592 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' B' ' 35' ' ' ASN . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.519 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.491 ' HA ' HD11 ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 33.9 t60 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.411 HG21 ' HG2' ' B' ' 21' ' ' LYS . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.437 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' B' ' 18' ' ' ASN . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.4 HG12 ' CD2' ' A' ' 47' ' ' PHE . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.558 HD13 ' HA ' ' B' ' 46' ' ' THR . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.443 ' HA ' ' HD2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.441 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.435 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.459 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.414 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.558 ' HA ' HD13 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' HE2' HG13 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 12' ' ' ILE . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.661 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HA ' HD11 ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 43.2 t60 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 3' ' ' ILE . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.471 HG22 HG22 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.5 ' CD2' HG12 ' A' ' 43' ' ' ILE . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.518 HG13 ' HE2' ' A' ' 1' ' ' MET . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 23' ' ' LEU . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.548 HG12 HG22 ' B' ' 12' ' ' ILE . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.409 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.653 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 43.2 t60 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.548 HG22 HG12 ' B' ' 3' ' ' ILE . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.653 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.536 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.497 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.452 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.404 HG22 HD21 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.497 HG12 ' CD2' ' B' ' 23' ' ' LEU . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.518 HD12 ' HE3' ' A' ' 32' ' ' LYS . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.494 ' HA ' HG13 ' A' ' 12' ' ' ILE . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 51.4 t60 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.411 HG11 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD22 HG12 ' A' ' 43' ' ' ILE . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 42' ' ' LYS . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.431 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.434 ' HA ' HD13 ' A' ' 23' ' ' LEU . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.616 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.549 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.522 HD12 ' HE3' ' B' ' 32' ' ' LYS . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.472 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 50.1 t60 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.472 HG22 HG12 ' B' ' 3' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.474 HG13 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG21 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.453 HD22 HG12 ' B' ' 43' ' ' ILE . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.652 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.453 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.509 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.437 ' HA ' HD13 ' B' ' 23' ' ' LEU . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.616 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HA ' HG11 ' A' ' 14' ' ' VAL . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.69 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG21 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD13 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.503 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HD13 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' B' ' 14' ' ' VAL . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.468 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.506 HD13 HG12 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.443 HG23 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.506 HG12 HD13 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLU . . . . . 0.557 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . 0.5 HG22 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 HD13 ' A' ' 12' ' ' ILE . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.613 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' HA ' HG21 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.647 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG22 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.605 HG23 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.647 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -64.38 140.7 58.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.87 110.62 1.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.309 0.575 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.44 -58.74 3.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.732 -0.605 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.46 148.73 48.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.843 -0.536 . . . . 0.0 109.658 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.2 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.757 2.305 . . . . 0.0 110.82 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.2 -38.93 2.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.693 -0.63 . . . . 0.0 110.21 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.106 -179.595 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.456 HG12 HD13 ' B' ' 12' ' ' ILE . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.403 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.621 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.443 ' HA ' HG21 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.44 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.529 HG12 HG22 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.621 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' B' ' 48' ' ' ILE . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.631 HD13 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.655 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.529 HG22 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.405 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.599 HG23 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.579 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.631 HG13 HD13 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.655 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.49 HG22 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -64.47 140.59 58.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.76 110.66 1.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.53 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.473 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.39 148.65 48.29 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.807 -0.558 . . . . 0.0 109.636 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.13 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.79 2.327 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.21 -38.92 2.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.804 -1.094 . . . . 0.0 110.134 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.688 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.563 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.47 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HG3' ' CG2' ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD13 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' A' ' 12' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.563 ' HD2' HG21 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' HA ' HD13 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.683 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.446 ' CG2' ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 -74.1 127.27 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 112.77 2.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.797 -0.564 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.48 -60.82 2.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.688 -0.632 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 6.0 t -168.11 142.69 2.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.776 -0.578 . . . . 0.0 109.584 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 36.5 Cg_endo -78.3 -97.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.533 2.155 . . . . 0.0 109.715 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.85 -2.75 1.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.442 -0.786 . . . . 0.0 111.406 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 109.732 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.671 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.561 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.479 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' B' ' 6' ' ' ILE . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.442 ' HG3' ' CG2' ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.571 ' HG ' ' CG2' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.68 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.454 HG23 ' CD1' ' B' ' 12' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.576 ' HD2' HG21 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.576 HG21 ' HD2' ' B' ' 32' ' ' LYS . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.488 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.516 ' HA ' HD13 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.68 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.617 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.442 ' CG2' ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -72.99 126.48 30.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.52 112.65 3.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.498 -0.752 . . . . 0.0 109.259 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.88 -60.16 2.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.736 -0.602 . . . . 0.0 109.659 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.9 t -168.43 143.19 2.79 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.708 -0.62 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.5 -97.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.626 2.218 . . . . 0.0 109.627 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.82 -2.78 1.31 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.339 -0.851 . . . . 0.0 111.371 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.702 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 31.8 t60 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.471 HG12 ' CG2' ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.702 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HG13 HG21 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' HD11 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.49 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 31' ' ' ASN . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' CG ' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' HB2' ' CG ' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.468 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 135.0 57.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -70.43 118.65 13.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.66 -0.65 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.95 -59.28 3.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.74 -0.6 . . . . 0.0 109.815 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 43.4 79.28 0.34 Allowed Pre-proline 0 N--CA 1.506 2.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -78.47 -71.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 123.131 2.554 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.45 -33.3 28.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.653 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.702 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.46 HD13 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.412 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 31.6 t60 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.422 HG13 HG21 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.487 ' HG ' ' CG2' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.52 HD11 ' HA3' ' B' ' 25' ' ' GLY . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.46 ' HG2' HD13 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.483 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.487 ' CG2' ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.534 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 135.05 57.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -70.41 118.59 13.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.91 -59.27 3.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.647 . . . . 0.0 109.768 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 43.43 79.26 0.34 Allowed Pre-proline 0 N--CA 1.505 2.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.3 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -78.45 -71.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.113 2.542 . . . . 0.0 110.838 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.56 -33.17 28.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.669 -0.645 . . . . 0.0 109.628 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.709 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.643 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.492 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.643 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.561 ' HG3' HG22 ' A' ' 48' ' ' ILE . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD22 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.448 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.583 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.466 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG12 HD22 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.539 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.457 HG21 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.561 HG22 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -58.04 108.72 0.63 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.58 129.39 55.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.748 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.68 -62.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.69 -0.631 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -145.46 139.77 15.24 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.742 -0.599 . . . . 0.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 -66.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.751 2.3 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.78 -54.07 1.54 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.612 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.639 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.572 ' HG3' HG22 ' B' ' 48' ' ' ILE . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.51 HD22 HG12 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' B' ' 38' ' ' VAL . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' B' ' 32' ' ' LYS . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.48 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.51 HG12 HD22 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.636 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.455 HG21 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.572 HG22 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -58.05 108.7 0.63 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.63 129.36 55.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.779 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.67 -62.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.676 -0.64 . . . . 0.0 109.516 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -145.47 139.83 15.3 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.727 -0.608 . . . . 0.0 109.59 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.37 -66.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.799 2.333 . . . . 0.0 110.805 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.76 -54.06 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.667 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HE2' HD12 ' A' ' 43' ' ' ILE . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.609 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.528 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 ' HB1' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB1' HD21 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.528 HG21 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' B' ' 47' ' ' PHE . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.532 ' CD2' HG12 ' A' ' 43' ' ' ILE . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.657 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.534 HG13 ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.497 HG21 ' HD3' ' A' ' 32' ' ' LYS . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.55 ' HA ' HD11 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.564 HD12 ' HE2' ' A' ' 1' ' ' MET . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -57.85 139.29 54.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 112.97 1.87 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.35 -43.57 69.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.744 -0.597 . . . . 0.0 109.809 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.0 p -69.74 146.63 95.85 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.82 -64.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.842 2.362 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -109.31 -53.5 2.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.551 ' HE2' HD12 ' B' ' 43' ' ' ILE . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.556 ' HA ' HG11 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.616 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.521 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.558 HD21 ' HB1' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.472 ' HA ' ' HB2' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.551 ' HB1' HD23 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.616 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.491 ' HB3' HG22 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 47' ' ' PHE . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.501 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.545 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.529 ' HD3' HG21 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.529 HG21 ' HD3' ' B' ' 32' ' ' LYS . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.448 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.541 ' HA ' HD11 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.545 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.551 HD12 ' HE2' ' B' ' 1' ' ' MET . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.619 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.578 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -57.63 138.37 55.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -60.62 114.44 2.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.691 -0.631 . . . . 0.0 109.667 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.35 -42.56 75.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.879 -0.513 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.2 p -68.89 145.97 97.1 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.726 -0.609 . . . . 0.0 109.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.13 -64.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.795 2.33 . . . . 0.0 110.633 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.28 -53.53 2.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.771 -0.58 . . . . 0.0 109.542 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.734 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' CE ' HD12 ' A' ' 43' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.672 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.468 ' HA ' HG13 ' A' ' 12' ' ' ILE . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.468 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.672 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD2' HG12 ' A' ' 43' ' ' ILE . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 32' ' ' LYS . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' A' ' 43' ' ' ILE . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.556 ' HD2' HG13 ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 -69.15 116.09 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.22 109.86 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.46 -54.38 2.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.661 -0.65 . . . . 0.0 109.595 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.6 m -78.33 134.78 62.18 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.738 -0.601 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.39 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.831 2.354 . . . . 0.0 110.769 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -57.72 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.616 -0.677 . . . . 0.0 109.718 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.499 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.522 ' CE ' HD12 ' B' ' 43' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.498 ' HA ' HG11 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.486 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.666 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.449 ' HA ' HG13 ' B' ' 12' ' ' ILE . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' B' ' 6' ' ' ILE . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.526 HG21 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.529 ' HB3' HG22 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.566 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' B' ' 32' ' ' LYS . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' B' ' 43' ' ' ILE . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.529 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.566 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.55 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.529 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 -68.13 115.1 7.22 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.77 109.63 13.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.741 -0.599 . . . . 0.0 109.512 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.32 -54.4 2.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.702 -0.624 . . . . 0.0 109.55 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -78.24 134.89 62.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.44 -70.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.778 2.319 . . . . 0.0 110.692 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.21 -57.59 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.466 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.487 ' HA ' HD11 ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 33.7 t60 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 18' ' ' ASN . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HE3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' B' ' 47' ' ' PHE . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 46' ' ' THR . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.453 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.55 ' HA ' HD13 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.542 HG22 ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.592 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -67.08 125.64 26.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.61 111.2 5.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.08 -58.65 2.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.653 -0.654 . . . . 0.0 109.679 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 p -136.53 148.52 64.16 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.79 -0.568 . . . . 0.0 109.749 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.71 -65.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.816 2.344 . . . . 0.0 110.604 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -106.77 -54.72 2.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.635 . . . . 0.0 109.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.72 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' B' ' 35' ' ' ASN . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.519 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.491 ' HA ' HD11 ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 33.9 t60 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.411 HG21 ' HG2' ' B' ' 21' ' ' LYS . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.437 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' B' ' 18' ' ' ASN . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.521 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.4 HG12 ' CD2' ' A' ' 47' ' ' PHE . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.558 HD13 ' HA ' ' B' ' 46' ' ' THR . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.443 ' HA ' ' HD2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.441 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.435 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.414 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' B' ' 2' ' ' LYS . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.506 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.459 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.511 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.414 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.558 ' HA ' HD13 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.613 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.521 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -66.99 125.55 26.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.62 111.24 5.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.75 -0.594 . . . . 0.0 109.453 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.31 -58.37 2.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.651 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.2 p -136.75 148.33 62.93 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.814 -0.554 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.61 -65.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.737 2.291 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.87 -54.75 2.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.76 -0.587 . . . . 0.0 109.455 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' HE2' HG13 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 12' ' ' ILE . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.661 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HA ' HD11 ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 43.2 t60 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.56 HG22 HG12 ' A' ' 3' ' ' ILE . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.471 HG22 HG22 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.5 ' CD2' HG12 ' A' ' 43' ' ' ILE . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.518 HG13 ' HE2' ' A' ' 1' ' ' MET . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' CD2' ' A' ' 23' ' ' LEU . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 -57.84 107.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.412 ' HE2' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -94.62 125.27 39.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.712 -0.618 . . . . 0.0 110.051 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -111.84 -58.13 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 3.3 p -141.03 127.87 11.75 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' HD3' ' HE2' ' A' ' 50' ' ' LYS . 35.2 Cg_endo -77.77 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.71 2.273 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' B' ' 54' ' ' ASP . 0.4 OUTLIER -80.26 -26.02 39.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.526 -0.734 . . . . 0.0 110.129 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.594 ' HB2' ' HB ' ' A' ' 52' ' ' THR . 36.6 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.83 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.548 HG12 HG22 ' B' ' 12' ' ' ILE . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.409 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.653 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.452 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 43.2 t60 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.548 HG22 HG12 ' B' ' 3' ' ' ILE . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.653 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.536 ' HB3' HG22 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.471 HG22 HG22 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.497 ' CD2' HG12 ' B' ' 43' ' ' ILE . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.452 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.404 HG22 HD21 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.497 HG12 ' CD2' ' B' ' 23' ' ' LEU . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.642 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -57.88 107.74 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.415 ' HE2' ' HD3' ' B' ' 53' ' ' PRO . 0.7 OUTLIER -94.59 125.16 39.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.655 -0.653 . . . . 0.0 110.118 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.71 -58.26 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' B' ' 55' ' ' TYR . 3.3 p -140.98 127.83 11.78 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.415 ' HD3' ' HE2' ' B' ' 50' ' ' LYS . 35.1 Cg_endo -77.71 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.749 2.299 . . . . 0.0 110.875 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -80.21 -26.02 39.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.458 -0.776 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' B' ' 52' ' ' THR . 36.8 m-85 . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.409 -0.807 . . . . 0.0 109.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.518 HD12 ' HE3' ' A' ' 32' ' ' LYS . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.494 ' HA ' HG13 ' A' ' 12' ' ' ILE . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 51.4 t60 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.411 HG11 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' HB3' HG22 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD22 HG12 ' A' ' 43' ' ' ILE . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG13 ' HB2' ' A' ' 42' ' ' LYS . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.431 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HA ' ' HD2' ' A' ' 32' ' ' LYS . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.5 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.474 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.434 ' HA ' HD13 ' A' ' 23' ' ' LEU . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.616 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.549 HG22 ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -61.75 112.43 2.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HD2' ' HB ' ' B' ' 48' ' ' ILE . 9.2 mttt -88.02 107.07 18.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.679 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.75 -55.45 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.707 -0.621 . . . . 0.0 109.43 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 38.8 p 43.63 79.65 0.32 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-O 120.78 0.324 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.77 -37.54 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 123.28 2.653 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -12.89 52.68 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.061 -0.399 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 117.617 -1.182 . . . . 0.0 111.045 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.522 HD12 ' HE3' ' B' ' 32' ' ' LYS . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.472 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 50.1 t60 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.472 HG22 HG12 ' B' ' 3' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.474 HG13 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.537 ' HB3' HG22 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG21 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.453 HD22 HG12 ' B' ' 43' ' ' ILE . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.652 ' HA ' ' HD2' ' B' ' 32' ' ' LYS . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.453 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.509 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.437 ' HA ' HD13 ' B' ' 23' ' ' LEU . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.616 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -61.69 112.39 2.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.484 ' HD2' ' HB ' ' A' ' 48' ' ' ILE . 9.4 mttt -87.95 107.05 18.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.754 . . . . 0.0 109.717 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.74 -55.44 3.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.456 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' B' ' 55' ' ' TYR . 39.1 p 43.69 79.59 0.33 Allowed Pre-proline 0 N--CA 1.505 2.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.78 -37.47 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.251 2.634 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.88 -12.8 52.85 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.919 -0.488 . . . . 0.0 111.154 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' B' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HA ' HG11 ' A' ' 14' ' ' VAL . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.69 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG21 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HG2' HG22 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 47' ' ' PHE . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD13 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.503 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.508 HG12 HD13 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.565 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -72.42 123.25 22.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -68.42 101.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.79 -48.52 7.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.648 -0.657 . . . . 0.0 109.652 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -74.65 120.91 83.8 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 35.1 Cg_endo -78.12 -63.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.768 2.312 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -122.99 -53.56 1.84 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.74 -0.6 . . . . 0.0 109.739 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 49.1 p90 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.419 ' HA ' HG11 ' B' ' 14' ' ' VAL . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.468 ' HA ' HG21 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' B' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.428 ' HA ' ' HB2' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 47' ' ' PHE . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.506 HD13 HG12 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.443 HG23 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.482 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' PRO . . . . . 0.504 ' HA ' ' CD1' ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.438 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.506 HG12 HD13 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLU . . . . . 0.557 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . 0.5 HG22 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -72.63 123.28 22.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -68.39 101.6 1.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.81 -48.44 7.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.659 -0.651 . . . . 0.0 109.672 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.9 p -74.79 120.91 83.83 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.811 -0.556 . . . . 0.0 109.674 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' CE2' ' B' ' 55' ' ' TYR . 35.1 Cg_endo -78.11 -63.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.809 2.339 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.07 -53.43 1.84 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' TYR . . . . . 0.43 ' CE2' ' HD2' ' B' ' 53' ' ' PRO . 48.9 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.495 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 33' ' ' LYS . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.648 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HA ' HG22 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' B' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.644 HG12 HG21 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.862 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.864 ' HG2' HG23 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' A' ' 13' ' ' VAL . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.644 HG21 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 3' ' ' ILE . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.702 HG21 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HA ' HD13 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.864 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.49 ' HB2' HG12 ' B' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 33' ' ' LYS . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.436 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.655 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.502 ' HA ' HG22 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.628 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.659 HG12 HG21 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' B' ' 22' ' ' ILE . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' B' ' 14' ' ' VAL . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' B' ' 13' ' ' VAL . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.659 HG21 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HD12 ' B' ' 3' ' ' ILE . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.699 HG21 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.589 ' HA ' HD13 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.665 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.858 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 33' ' ' LYS . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' B' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.736 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 5' ' ' ARG . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.812 ' HA ' HD13 ' A' ' 22' ' ' ILE . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' OE1' HG22 ' A' ' 48' ' ' ILE . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.976 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.812 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.971 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD11 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.713 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HD2' HG23 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 1' ' ' MET . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.971 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.778 HG23 HD11 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.713 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.976 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.555 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 33' ' ' LYS . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.496 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 5' ' ' ARG . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.8 ' HA ' HD13 ' B' ' 22' ' ' ILE . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' B' ' 21' ' ' LYS . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.545 ' OE1' HG22 ' B' ' 48' ' ' ILE . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.972 ' HG3' HG23 ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' B' ' 13' ' ' VAL . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.974 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' B' ' 28' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.696 ' HD2' HG23 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.494 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.555 HG23 ' O ' ' B' ' 1' ' ' MET . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.974 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.769 HG23 HD11 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.712 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.972 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 37' ' ' ILE . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.577 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG21 HG12 ' A' ' 12' ' ' ILE . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 37' ' ' ILE . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 1' ' ' MET . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.773 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.79 HG23 HD11 ' A' ' 23' ' ' LEU . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.649 ' O ' HG23 ' B' ' 37' ' ' ILE . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.683 HD11 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.427 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.522 HG12 HG21 ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.578 ' CD1' HG13 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.522 HG21 HG12 ' B' ' 12' ' ' ILE . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.683 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.649 HG23 ' O ' ' B' ' 1' ' ' MET . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.868 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.463 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.745 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.811 HG23 HD11 ' B' ' 23' ' ' LEU . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' HG12 ' A' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HE3' HG23 ' A' ' 46' ' ' THR . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.621 HD12 HD11 ' A' ' 7' ' ' LEU . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.869 HD11 HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.725 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 23' ' ' LEU . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.869 HG23 HD11 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB3' HG12 ' B' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.727 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.749 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.614 HD11 HD12 ' B' ' 22' ' ' ILE . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.1 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.647 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' B' ' 46' ' ' THR . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.614 HD12 HD11 ' B' ' 7' ' ' LEU . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.887 HD11 HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.692 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.598 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.727 ' O ' HD12 ' B' ' 3' ' ' ILE . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.762 HG21 ' HG ' ' B' ' 23' ' ' LEU . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.487 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.774 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.887 HG23 HD11 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.564 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.59 HG23 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.511 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' HG11 ' A' ' 38' ' ' VAL . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.627 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.751 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 26' ' ' ALA . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.689 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.751 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 7' ' ' LEU . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' A' ' 38' ' ' VAL . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD3' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HD12 ' A' ' 3' ' ' ILE . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.728 HG11 ' CD2' ' A' ' 23' ' ' LEU . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 40' ' ' PRO . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.673 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.434 ' HE3' HG11 ' B' ' 38' ' ' VAL . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.649 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.762 HG22 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.629 ' CD1' HG22 ' B' ' 13' ' ' VAL . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.738 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 22' ' ' ILE . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD3' HG23 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' B' ' 36' ' ' ASP . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.553 ' O ' HD12 ' B' ' 3' ' ' ILE . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.738 HG11 ' CD2' ' B' ' 23' ' ' LEU . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.841 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.642 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.515 HD13 ' C ' ' A' ' 5' ' ' ARG . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 22' ' ' ILE . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.697 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.683 ' HB3' HG23 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 7' ' ' LEU . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HG11 ' A' ' 38' ' ' VAL . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.581 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 3' ' ' ILE . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 23' ' ' LEU . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.559 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.49 ' HA ' HG12 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.476 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.519 HD13 ' C ' ' B' ' 5' ' ' ARG . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.745 HD11 HD12 ' B' ' 22' ' ' ILE . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.494 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 7' ' ' LEU . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.679 ' HB3' HG23 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.745 HD12 HD11 ' B' ' 7' ' ' LEU . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.801 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.585 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' ILE . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.801 HG11 ' CD2' ' B' ' 23' ' ' LEU . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.569 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.924 ' HA ' HD12 ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 37' ' ' ILE . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 3' ' ' ILE . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 22' ' ' ILE . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.748 ' CD1' HG23 ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 22' ' ' ILE . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.616 HG21 HD22 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.697 HD12 HD11 ' A' ' 7' ' ' LEU . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 1' ' ' MET . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 23' ' ' LEU . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.866 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.648 ' O ' HG23 ' B' ' 37' ' ' ILE . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 15' ' ' LYS . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.755 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.698 HD11 HD12 ' B' ' 22' ' ' ILE . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.755 ' CD1' HG23 ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' B' ' 22' ' ' ILE . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.63 HG21 HD22 ' B' ' 23' ' ' LEU . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 4' ' ' LYS . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.444 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.506 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.758 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.698 HD12 HD11 ' B' ' 7' ' ' LEU . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.891 ' CD2' HG11 ' B' ' 38' ' ' VAL . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.461 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.477 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ILE . . . . . 0.648 HG23 ' O ' ' B' ' 1' ' ' MET . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' B' ' 23' ' ' LEU . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.461 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.842 ' HA ' HD12 ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.418 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.447 ' HA ' HD12 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.685 ' HE3' HG11 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.677 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' CD1' ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 12' ' ' ILE . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 29' ' ' ALA . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 23' ' ' LEU . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 HG21 ' A' ' 38' ' ' VAL . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD11 HD11 ' B' ' 22' ' ' ILE . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.625 ' O ' HD12 ' A' ' 3' ' ' ILE . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.812 HG21 HD23 ' A' ' 23' ' ' LEU . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.644 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 40' ' ' PRO . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.413 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' ' 12' ' ' ILE . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 29' ' ' ALA . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 23' ' ' LEU . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.509 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.816 HD23 HG21 ' B' ' 38' ' ' VAL . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 22' ' ' ILE . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' B' ' 25' ' ' GLY . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.632 ' O ' HD12 ' B' ' 3' ' ' ILE . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 HD23 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.634 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD11 ' A' ' 43' ' ' ILE . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 14' ' ' VAL . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' LYS . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' B' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 20.7 t-80 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG12 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.769 HD23 HG21 ' A' ' 38' ' ' VAL . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.565 HG23 HD13 ' A' ' 12' ' ' ILE . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.405 ' HE1' HD11 ' B' ' 43' ' ' ILE . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.525 HG12 HG21 ' B' ' 12' ' ' ILE . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.798 HG23 ' CD1' ' B' ' 12' ' ' ILE . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.422 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 20.0 t-80 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' B' ' 6' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.514 HG12 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG22 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.746 HD23 HG21 ' B' ' 38' ' ' VAL . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.413 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.413 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' B' ' 6' ' ' ILE . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.746 HG21 HD23 ' B' ' 23' ' ' LEU . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG12 ' A' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG12 HD12 ' A' ' 12' ' ' ILE . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.703 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 22' ' ' ILE . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.867 ' HG2' HG23 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.902 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.902 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.867 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.499 ' HB3' HG12 ' B' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.516 HD12 ' O ' ' B' ' 33' ' ' LYS . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.686 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' HIS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.85 ' HA ' HD13 ' B' ' 22' ' ' ILE . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.878 ' HG2' HG23 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.908 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.468 HG21 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.908 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.494 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.807 HG23 HD11 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLU . . . . . 0.571 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.878 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 33' ' ' LYS . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.648 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HA ' HG22 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' B' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.644 HG12 HG21 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.862 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.864 ' HG2' HG23 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' A' ' 13' ' ' VAL . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.644 HG21 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 3' ' ' ILE . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.702 HG21 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HA ' HD13 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.864 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -64.38 140.7 58.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.87 110.62 1.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.309 0.575 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.44 -58.74 3.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.732 -0.605 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.46 148.73 48.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.843 -0.536 . . . . 0.0 109.658 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.2 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.757 2.305 . . . . 0.0 110.82 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.2 -38.93 2.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.693 -0.63 . . . . 0.0 110.21 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.106 -179.595 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.49 ' HB2' HG12 ' B' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 33' ' ' LYS . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.436 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.655 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.502 ' HA ' HG22 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.628 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.659 HG12 HG21 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' B' ' 22' ' ' ILE . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' B' ' 14' ' ' VAL . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' B' ' 13' ' ' VAL . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.659 HG21 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HD12 ' B' ' 3' ' ' ILE . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.699 HG21 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.589 ' HA ' HD13 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.665 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.858 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -64.47 140.59 58.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.76 110.66 1.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.53 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.473 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.39 148.65 48.29 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.807 -0.558 . . . . 0.0 109.636 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.13 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.79 2.327 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.21 -38.92 2.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.804 -1.094 . . . . 0.0 110.134 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 33' ' ' LYS . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' B' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.736 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 5' ' ' ARG . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.812 ' HA ' HD13 ' A' ' 22' ' ' ILE . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' OE1' HG22 ' A' ' 48' ' ' ILE . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.976 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.812 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.971 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD11 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.713 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HD2' HG23 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 1' ' ' MET . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.971 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.778 HG23 HD11 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.713 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.976 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 -74.1 127.27 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 112.77 2.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.797 -0.564 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.48 -60.82 2.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.688 -0.632 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 6.0 t -168.11 142.69 2.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.776 -0.578 . . . . 0.0 109.584 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 36.5 Cg_endo -78.3 -97.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.533 2.155 . . . . 0.0 109.715 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.85 -2.75 1.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.442 -0.786 . . . . 0.0 111.406 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 109.732 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.555 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 33' ' ' LYS . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.496 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 5' ' ' ARG . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.8 ' HA ' HD13 ' B' ' 22' ' ' ILE . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' B' ' 21' ' ' LYS . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.545 ' OE1' HG22 ' B' ' 48' ' ' ILE . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.972 ' HG3' HG23 ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' B' ' 13' ' ' VAL . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.974 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' B' ' 28' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.696 ' HD2' HG23 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.494 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.555 HG23 ' O ' ' B' ' 1' ' ' MET . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.974 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.769 HG23 HD11 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.712 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.972 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -72.99 126.48 30.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.52 112.65 3.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.498 -0.752 . . . . 0.0 109.259 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.88 -60.16 2.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.736 -0.602 . . . . 0.0 109.659 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.9 t -168.43 143.19 2.79 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.708 -0.62 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.5 -97.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.626 2.218 . . . . 0.0 109.627 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.82 -2.78 1.31 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.339 -0.851 . . . . 0.0 111.371 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 37' ' ' ILE . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.577 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG21 HG12 ' A' ' 12' ' ' ILE . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 37' ' ' ILE . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 1' ' ' MET . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.773 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.79 HG23 HD11 ' A' ' 23' ' ' LEU . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 135.0 57.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -70.43 118.65 13.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.66 -0.65 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.95 -59.28 3.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.74 -0.6 . . . . 0.0 109.815 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 43.4 79.28 0.34 Allowed Pre-proline 0 N--CA 1.506 2.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -78.47 -71.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 123.131 2.554 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.45 -33.3 28.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.653 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.702 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.649 ' O ' HG23 ' B' ' 37' ' ' ILE . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.683 HD11 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.427 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.522 HG12 HG21 ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.578 ' CD1' HG13 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.522 HG21 HG12 ' B' ' 12' ' ' ILE . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.683 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.649 HG23 ' O ' ' B' ' 1' ' ' MET . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.868 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.463 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.745 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.811 HG23 HD11 ' B' ' 23' ' ' LEU . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 135.05 57.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -70.41 118.59 13.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.91 -59.27 3.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.647 . . . . 0.0 109.768 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 43.43 79.26 0.34 Allowed Pre-proline 0 N--CA 1.505 2.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.3 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -78.45 -71.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.113 2.542 . . . . 0.0 110.838 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.56 -33.17 28.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.669 -0.645 . . . . 0.0 109.628 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.709 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' HG12 ' A' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HE3' HG23 ' A' ' 46' ' ' THR . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.621 HD12 HD11 ' A' ' 7' ' ' LEU . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.869 HD11 HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.725 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 23' ' ' LEU . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.869 HG23 HD11 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -58.04 108.72 0.63 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HB3' HD12 ' B' ' 48' ' ' ILE . 0.4 OUTLIER -118.58 129.39 55.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.748 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.68 -62.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.69 -0.631 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -145.46 139.77 15.24 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.742 -0.599 . . . . 0.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 -66.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.751 2.3 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.78 -54.07 1.54 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.612 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB3' HG12 ' B' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.727 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.749 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.614 HD11 HD12 ' B' ' 22' ' ' ILE . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.1 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.647 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' B' ' 46' ' ' THR . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.614 HD12 HD11 ' B' ' 7' ' ' LEU . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.887 HD11 HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.692 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.598 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.727 ' O ' HD12 ' B' ' 3' ' ' ILE . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.762 HG21 ' HG ' ' B' ' 23' ' ' LEU . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.487 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.774 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.887 HG23 HD11 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.564 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.59 HG23 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.511 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -58.05 108.7 0.63 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LYS . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.63 129.36 55.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.779 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.67 -62.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.676 -0.64 . . . . 0.0 109.516 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -145.47 139.83 15.3 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.727 -0.608 . . . . 0.0 109.59 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.37 -66.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.799 2.333 . . . . 0.0 110.805 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.76 -54.06 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.667 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' HG11 ' A' ' 38' ' ' VAL . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.627 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.751 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 26' ' ' ALA . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.689 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.751 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 7' ' ' LEU . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' A' ' 38' ' ' VAL . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD3' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HD12 ' A' ' 3' ' ' ILE . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.728 HG11 ' CD2' ' A' ' 23' ' ' LEU . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 40' ' ' PRO . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.673 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -57.85 139.29 54.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 112.97 1.87 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.35 -43.57 69.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.744 -0.597 . . . . 0.0 109.809 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 25.0 p -69.74 146.63 95.85 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 33.8 Cg_endo -76.82 -64.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.842 2.362 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -109.31 -53.5 2.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.434 ' HE3' HG11 ' B' ' 38' ' ' VAL . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.649 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.762 HG22 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.629 ' CD1' HG22 ' B' ' 13' ' ' VAL . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.738 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 22' ' ' ILE . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD3' HG23 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' B' ' 36' ' ' ASP . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.553 ' O ' HD12 ' B' ' 3' ' ' ILE . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.738 HG11 ' CD2' ' B' ' 23' ' ' LEU . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.841 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.642 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -57.63 138.37 55.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -60.62 114.44 2.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.691 -0.631 . . . . 0.0 109.667 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.35 -42.56 75.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.879 -0.513 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.2 p -68.89 145.97 97.1 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.726 -0.609 . . . . 0.0 109.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.13 -64.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.795 2.33 . . . . 0.0 110.633 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.28 -53.53 2.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.771 -0.58 . . . . 0.0 109.542 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.734 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.515 HD13 ' C ' ' A' ' 5' ' ' ARG . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 22' ' ' ILE . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.697 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.683 ' HB3' HG23 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 7' ' ' LEU . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HG11 ' A' ' 38' ' ' VAL . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.581 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 3' ' ' ILE . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 23' ' ' LEU . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.559 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 -69.15 116.09 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.22 109.86 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.46 -54.38 2.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.661 -0.65 . . . . 0.0 109.595 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.6 m -78.33 134.78 62.18 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.738 -0.601 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.39 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.831 2.354 . . . . 0.0 110.769 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -57.72 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.616 -0.677 . . . . 0.0 109.718 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.499 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.49 ' HA ' HG12 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.476 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.519 HD13 ' C ' ' B' ' 5' ' ' ARG . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.745 HD11 HD12 ' B' ' 22' ' ' ILE . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.494 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 7' ' ' LEU . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.679 ' HB3' HG23 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.745 HD12 HD11 ' B' ' 7' ' ' LEU . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.801 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.585 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' ILE . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.801 HG11 ' CD2' ' B' ' 23' ' ' LEU . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.569 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.924 ' HA ' HD12 ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 -68.13 115.1 7.22 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.77 109.63 13.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.741 -0.599 . . . . 0.0 109.512 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.32 -54.4 2.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.702 -0.624 . . . . 0.0 109.55 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -78.24 134.89 62.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.44 -70.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.778 2.319 . . . . 0.0 110.692 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.21 -57.59 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.466 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 37' ' ' ILE . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 3' ' ' ILE . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 22' ' ' ILE . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.748 ' CD1' HG23 ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 22' ' ' ILE . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.616 HG21 HD22 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.697 HD12 HD11 ' A' ' 7' ' ' LEU . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 1' ' ' MET . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 23' ' ' LEU . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.866 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -67.08 125.64 26.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.61 111.2 5.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.08 -58.65 2.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.653 -0.654 . . . . 0.0 109.679 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 p -136.53 148.52 64.16 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.79 -0.568 . . . . 0.0 109.749 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.71 -65.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.816 2.344 . . . . 0.0 110.604 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -106.77 -54.72 2.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.635 . . . . 0.0 109.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.72 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.648 ' O ' HG23 ' B' ' 37' ' ' ILE . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 15' ' ' LYS . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.755 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.698 HD11 HD12 ' B' ' 22' ' ' ILE . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.755 ' CD1' HG23 ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' B' ' 22' ' ' ILE . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.63 HG21 HD22 ' B' ' 23' ' ' LEU . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 4' ' ' LYS . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.444 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.506 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.758 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.698 HD12 HD11 ' B' ' 7' ' ' LEU . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.891 ' CD2' HG11 ' B' ' 38' ' ' VAL . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.461 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.477 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ILE . . . . . 0.648 HG23 ' O ' ' B' ' 1' ' ' MET . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' B' ' 23' ' ' LEU . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.461 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.842 ' HA ' HD12 ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.418 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.447 ' HA ' HD12 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -66.99 125.55 26.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.62 111.24 5.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.75 -0.594 . . . . 0.0 109.453 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.31 -58.37 2.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.651 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.2 p -136.75 148.33 62.93 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.814 -0.554 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.61 -65.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.737 2.291 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.87 -54.75 2.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.76 -0.587 . . . . 0.0 109.455 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.685 ' HE3' HG11 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.677 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' CD1' ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 12' ' ' ILE . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 29' ' ' ALA . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 23' ' ' LEU . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 HG21 ' A' ' 38' ' ' VAL . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD11 HD11 ' B' ' 22' ' ' ILE . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.625 ' O ' HD12 ' A' ' 3' ' ' ILE . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.812 HG21 HD23 ' A' ' 23' ' ' LEU . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.644 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 40' ' ' PRO . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 -57.84 107.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HE2' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -94.62 125.27 39.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.712 -0.618 . . . . 0.0 110.051 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -111.84 -58.13 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 3.3 p -141.03 127.87 11.75 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 50' ' ' LYS . 35.2 Cg_endo -77.77 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.71 2.273 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' B' ' 54' ' ' ASP . 0.4 OUTLIER -80.26 -26.02 39.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.526 -0.734 . . . . 0.0 110.129 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 52' ' ' THR . 36.6 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.83 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.413 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' ' 12' ' ' ILE . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 29' ' ' ALA . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 23' ' ' LEU . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.509 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.816 HD23 HG21 ' B' ' 38' ' ' VAL . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 22' ' ' ILE . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' B' ' 25' ' ' GLY . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.632 ' O ' HD12 ' B' ' 3' ' ' ILE . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 HD23 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.634 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -57.88 107.74 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' B' ' 53' ' ' PRO . 0.7 OUTLIER -94.59 125.16 39.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.655 -0.653 . . . . 0.0 110.118 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.71 -58.26 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' B' ' 55' ' ' TYR . 3.3 p -140.98 127.83 11.78 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.416 ' HD3' ' HE2' ' B' ' 50' ' ' LYS . 35.1 Cg_endo -77.71 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.749 2.299 . . . . 0.0 110.875 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -80.21 -26.02 39.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.458 -0.776 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' B' ' 52' ' ' THR . 36.8 m-85 . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.409 -0.807 . . . . 0.0 109.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD11 ' A' ' 43' ' ' ILE . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 14' ' ' VAL . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' LYS . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' B' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 20.7 t-80 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG12 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.769 HD23 HG21 ' A' ' 38' ' ' VAL . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.565 HG23 HD13 ' A' ' 12' ' ' ILE . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.518 ' HB ' ' HD2' ' B' ' 50' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -61.75 112.43 2.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD2' ' HB ' ' B' ' 48' ' ' ILE . 9.2 mttt -88.02 107.07 18.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.679 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.75 -55.45 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.707 -0.621 . . . . 0.0 109.43 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 38.8 p 43.63 79.65 0.32 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-O 120.78 0.324 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.77 -37.54 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 123.28 2.653 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -12.89 52.68 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.061 -0.399 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 117.617 -1.182 . . . . 0.0 111.045 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.405 ' HE1' HD11 ' B' ' 43' ' ' ILE . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.525 HG12 HG21 ' B' ' 12' ' ' ILE . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.798 HG23 ' CD1' ' B' ' 12' ' ' ILE . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.422 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 20.0 t-80 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' B' ' 6' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.514 HG12 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG22 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.746 HD23 HG21 ' B' ' 38' ' ' VAL . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.413 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.413 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' B' ' 6' ' ' ILE . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.746 HG21 HD23 ' B' ' 23' ' ' LEU . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.547 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -61.69 112.39 2.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 48' ' ' ILE . 9.4 mttt -87.95 107.05 18.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.754 . . . . 0.0 109.717 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.74 -55.44 3.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.456 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' B' ' 55' ' ' TYR . 39.1 p 43.69 79.59 0.33 Allowed Pre-proline 0 N--CA 1.505 2.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.78 -37.47 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.251 2.634 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.88 -12.8 52.85 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.919 -0.488 . . . . 0.0 111.154 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' B' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG12 ' A' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG12 HD12 ' A' ' 12' ' ' ILE . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.703 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 22' ' ' ILE . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.867 ' HG2' HG23 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.902 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.902 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.867 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -72.42 123.25 22.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -68.42 101.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.79 -48.52 7.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.648 -0.657 . . . . 0.0 109.652 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -74.65 120.91 83.8 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 35.1 Cg_endo -78.12 -63.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.768 2.312 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -122.99 -53.56 1.84 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.74 -0.6 . . . . 0.0 109.739 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 49.1 p90 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.499 ' HB3' HG12 ' B' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.516 HD12 ' O ' ' B' ' 33' ' ' LYS . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.686 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.85 ' HA ' HD13 ' B' ' 22' ' ' ILE . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.878 ' HG2' HG23 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.908 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.468 HG21 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.908 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.494 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.807 HG23 HD11 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLU . . . . . 0.571 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.878 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -72.63 123.28 22.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -68.39 101.6 1.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.81 -48.44 7.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.659 -0.651 . . . . 0.0 109.672 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.9 p -74.79 120.91 83.83 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.811 -0.556 . . . . 0.0 109.674 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' B' ' 55' ' ' TYR . 35.1 Cg_endo -78.11 -63.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.809 2.339 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.07 -53.43 1.84 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' B' ' 53' ' ' PRO . 48.9 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.495 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 33' ' ' LYS . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.648 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HA ' HG22 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' B' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.644 HG12 HG21 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.862 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.864 ' HG2' HG23 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' A' ' 13' ' ' VAL . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.644 HG21 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 3' ' ' ILE . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.702 HG21 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HA ' HD13 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.864 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.49 ' HB2' HG12 ' B' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 33' ' ' LYS . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.436 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.655 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.502 ' HA ' HG22 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.628 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.659 HG12 HG21 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' B' ' 22' ' ' ILE . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' B' ' 14' ' ' VAL . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' B' ' 13' ' ' VAL . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.659 HG21 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HD12 ' B' ' 3' ' ' ILE . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.699 HG21 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.589 ' HA ' HD13 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.665 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.858 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 33' ' ' LYS . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' B' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.736 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 5' ' ' ARG . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.812 ' HA ' HD13 ' A' ' 22' ' ' ILE . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' OE1' HG22 ' A' ' 48' ' ' ILE . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.976 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.812 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.971 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD11 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.713 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HD2' HG23 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 1' ' ' MET . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.971 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.778 HG23 HD11 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.713 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.976 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.555 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 33' ' ' LYS . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.496 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.722 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 5' ' ' ARG . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.8 ' HA ' HD13 ' B' ' 22' ' ' ILE . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' B' ' 21' ' ' LYS . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.545 ' OE1' HG22 ' B' ' 48' ' ' ILE . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.972 ' HG3' HG23 ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' B' ' 13' ' ' VAL . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.974 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' B' ' 28' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.696 ' HD2' HG23 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.494 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.555 HG23 ' O ' ' B' ' 1' ' ' MET . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.974 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.769 HG23 HD11 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.712 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.972 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 37' ' ' ILE . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 31.8 t60 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.577 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG21 HG12 ' A' ' 12' ' ' ILE . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.497 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 37' ' ' ILE . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 1' ' ' MET . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.773 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.79 HG23 HD11 ' A' ' 23' ' ' LEU . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.649 ' O ' HG23 ' B' ' 37' ' ' ILE . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.683 HD11 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.427 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 31.6 t60 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.522 HG12 HG21 ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.578 ' CD1' HG13 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.522 HG21 HG12 ' B' ' 12' ' ' ILE . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.683 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.649 HG23 ' O ' ' B' ' 1' ' ' MET . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.868 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.463 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.745 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.811 HG23 HD11 ' B' ' 23' ' ' LEU . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' HG12 ' A' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HE3' HG23 ' A' ' 46' ' ' THR . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.621 HD12 HD11 ' A' ' 7' ' ' LEU . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.869 HD11 HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.725 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 23' ' ' LEU . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.869 HG23 HD11 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB3' HG12 ' B' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.727 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.749 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.614 HD11 HD12 ' B' ' 22' ' ' ILE . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.4 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.647 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' B' ' 46' ' ' THR . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.614 HD12 HD11 ' B' ' 7' ' ' LEU . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.887 HD11 HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.692 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.598 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.727 ' O ' HD12 ' B' ' 3' ' ' ILE . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.762 HG21 ' HG ' ' B' ' 23' ' ' LEU . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.487 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.774 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.887 HG23 HD11 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.564 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.59 HG23 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.511 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' HG11 ' A' ' 38' ' ' VAL . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.627 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.751 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 26' ' ' ALA . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.689 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.751 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 7' ' ' LEU . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' A' ' 38' ' ' VAL . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD3' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HD12 ' A' ' 3' ' ' ILE . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.728 HG11 ' CD2' ' A' ' 23' ' ' LEU . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 40' ' ' PRO . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.673 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.434 ' HE3' HG11 ' B' ' 38' ' ' VAL . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.649 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.762 HG22 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.629 ' CD1' HG22 ' B' ' 13' ' ' VAL . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.738 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 22' ' ' ILE . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD3' HG23 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' B' ' 36' ' ' ASP . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.553 ' O ' HD12 ' B' ' 3' ' ' ILE . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.738 HG11 ' CD2' ' B' ' 23' ' ' LEU . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.841 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.642 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.515 HD13 ' C ' ' A' ' 5' ' ' ARG . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 22' ' ' ILE . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.697 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.683 ' HB3' HG23 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 7' ' ' LEU . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HG11 ' A' ' 38' ' ' VAL . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.581 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 3' ' ' ILE . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 23' ' ' LEU . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.559 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.49 ' HA ' HG12 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.476 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.519 HD13 ' C ' ' B' ' 5' ' ' ARG . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.745 HD11 HD12 ' B' ' 22' ' ' ILE . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.494 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 7' ' ' LEU . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.679 ' HB3' HG23 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.745 HD12 HD11 ' B' ' 7' ' ' LEU . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.801 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.585 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' ILE . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.801 HG11 ' CD2' ' B' ' 23' ' ' LEU . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.569 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.924 ' HA ' HD12 ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 . . . . . 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 37' ' ' ILE . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 3' ' ' ILE . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.537 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 22' ' ' ILE . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 33.7 t60 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.748 ' CD1' HG23 ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 22' ' ' ILE . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.616 HG21 HD22 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.697 HD12 HD11 ' A' ' 7' ' ' LEU . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.445 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 1' ' ' MET . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 23' ' ' LEU . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.866 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.648 ' O ' HG23 ' B' ' 37' ' ' ILE . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 15' ' ' LYS . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.755 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.698 HD11 HD12 ' B' ' 22' ' ' ILE . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 33.9 t60 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.755 ' CD1' HG23 ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' B' ' 22' ' ' ILE . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.63 HG21 HD22 ' B' ' 23' ' ' LEU . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 4' ' ' LYS . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.444 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.506 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.758 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.698 HD12 HD11 ' B' ' 7' ' ' LEU . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.891 ' CD2' HG11 ' B' ' 38' ' ' VAL . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.461 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.477 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . 0.648 HG23 ' O ' ' B' ' 1' ' ' MET . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' B' ' 23' ' ' LEU . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.461 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.842 ' HA ' HD12 ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.418 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.447 ' HA ' HD12 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.685 ' HE3' HG11 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.677 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' CD1' ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 12' ' ' ILE . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 43.2 t60 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 29' ' ' ALA . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 23' ' ' LEU . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 HG21 ' A' ' 38' ' ' VAL . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD11 HD11 ' B' ' 22' ' ' ILE . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.625 ' O ' HD12 ' A' ' 3' ' ' ILE . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.812 HG21 HD23 ' A' ' 23' ' ' LEU . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.644 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 40' ' ' PRO . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.413 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' ' 12' ' ' ILE . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 43.2 t60 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 29' ' ' ALA . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 23' ' ' LEU . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.509 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.816 HD23 HG21 ' B' ' 38' ' ' VAL . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 22' ' ' ILE . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' B' ' 25' ' ' GLY . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.632 ' O ' HD12 ' B' ' 3' ' ' ILE . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 HD23 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.634 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD11 ' A' ' 43' ' ' ILE . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 14' ' ' VAL . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' LYS . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' B' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 51.4 t60 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG12 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.769 HD23 HG21 ' A' ' 38' ' ' VAL . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.565 HG23 HD13 ' A' ' 12' ' ' ILE . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.405 ' HE1' HD11 ' B' ' 43' ' ' ILE . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.525 HG12 HG21 ' B' ' 12' ' ' ILE . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.798 HG23 ' CD1' ' B' ' 12' ' ' ILE . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 50.1 t60 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' B' ' 6' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.514 HG12 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG22 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.746 HD23 HG21 ' B' ' 38' ' ' VAL . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.413 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' B' ' 6' ' ' ILE . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.746 HG21 HD23 ' B' ' 23' ' ' LEU . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.495 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG12 ' A' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG12 HD12 ' A' ' 12' ' ' ILE . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.703 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 22' ' ' ILE . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.867 ' HG2' HG23 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.902 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.902 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.867 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.499 ' HB3' HG12 ' B' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.516 HD12 ' O ' ' B' ' 33' ' ' LYS . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.686 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' HIS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.85 ' HA ' HD13 ' B' ' 22' ' ' ILE . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.878 ' HG2' HG23 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.908 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.468 HG21 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.908 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.494 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.807 HG23 HD11 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLU . . . . . 0.571 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.878 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.44 172.03 8.33 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.611 0.719 . . . . 0.0 109.705 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 33' ' ' LYS . 65.5 mt -108.41 106.45 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 6.4 tttm -82.98 -32.78 26.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.757 -0.589 . . . . 0.0 109.81 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.648 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -144.21 174.42 10.9 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.662 0.744 . . . . 0.0 110.371 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' HA ' HG22 ' A' ' 12' ' ' ILE . 18.8 mm -130.92 121.25 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' B' ' 11' ' ' ALA . 16.7 mt -87.96 -47.41 8.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -162.24 -152.61 0.24 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.638 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -81.11 1.59 31.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.969 -1.082 . . . . 0.0 110.943 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' GLY . 1.8 m-80 -134.09 -41.55 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 110.364 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.69 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -93.12 139.93 30.05 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.516 -0.74 . . . . 0.0 110.253 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.644 HG12 HG21 ' A' ' 28' ' ' ILE . 4.6 pt -149.21 147.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.73 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.3 t -89.33 107.95 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.862 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.6 m -101.63 -176.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.698 -0.626 . . . . 0.0 109.714 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -144.34 125.97 15.06 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.548 -0.72 . . . . 0.0 109.45 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' HG3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -112.46 -176.81 3.0 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.374 0.607 . . . . 0.0 109.844 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -43.32 94.32 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.626 -0.671 . . . . 0.0 110.028 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.33 -53.08 60.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.213 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.2 -157.09 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.593 -0.692 . . . . 0.0 109.422 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.95 144.55 54.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.481 -0.762 . . . . 0.0 109.749 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.864 ' HG2' HG23 ' A' ' 48' ' ' ILE . 8.5 mtmt -130.87 175.46 9.04 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.428 0.633 . . . . 0.0 109.642 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.73 HD13 ' HA ' ' A' ' 13' ' ' VAL . 16.2 mm -134.26 123.77 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.78 108.47 20.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.495 -0.753 . . . . 0.0 110.185 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 20.5 mt -102.37 105.26 15.83 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.656 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -144.28 120.84 1.5 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.71 105.53 0.14 Allowed 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.752 0.787 . . . . 0.0 110.447 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.33 8.89 58.4 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.644 HG21 HG12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -57.66 -47.23 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.614 -0.933 . . . . 0.0 109.41 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.638 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.44 -37.9 79.32 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.17 143.58 50.47 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.55 26.6 3.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.765 -0.584 . . . . 0.0 110.307 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.23 174.82 5.94 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.948 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 3' ' ' ILE . 60.3 pttt -152.79 174.63 13.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.405 -0.809 . . . . 0.0 110.433 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.1 tmtt? -61.53 132.29 52.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.683 -0.636 . . . . 0.0 109.986 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 1.3 t-20 83.54 -10.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.69 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.23 151.42 24.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.124 -0.985 . . . . 0.0 108.879 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.7 mm -63.47 146.96 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.702 HG21 ' HG ' ' A' ' 23' ' ' LEU . 7.2 p -79.17 136.87 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.615 -0.678 . . . . 0.0 109.939 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.74 124.41 90.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HA ' HD13 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.15 -34.1 13.88 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.391 2.061 . . . . 0.0 110.895 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -27.85 69.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 3.3 mttt -87.08 -18.87 29.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.809 -0.557 . . . . 0.0 110.052 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 23' ' ' LEU . 1.2 mp -55.13 116.25 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.471 -0.768 . . . . 0.0 109.25 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.656 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 6.2 mt-10 -116.85 -29.42 6.03 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.72 122.6 3.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.599 -0.688 . . . . 0.0 109.983 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -105.72 124.43 49.55 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.4 m-85 -118.66 144.36 46.23 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.437 0.637 . . . . 0.0 110.395 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.864 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -131.37 137.05 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -64.38 140.7 58.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.628 -0.67 . . . . 0.0 109.697 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.87 110.62 1.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.309 0.575 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.44 -58.74 3.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.732 -0.605 . . . . 0.0 109.528 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.46 148.73 48.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.843 -0.536 . . . . 0.0 109.658 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.2 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.757 2.305 . . . . 0.0 110.82 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.2 -38.93 2.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.693 -0.63 . . . . 0.0 110.21 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 117.836 -1.078 . . . . 0.0 110.106 -179.595 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.49 ' HB2' HG12 ' B' ' 38' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -95.41 172.06 8.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.571 0.701 . . . . 0.0 109.727 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.597 HD12 ' O ' ' B' ' 33' ' ' LYS . 65.7 mt -108.48 106.37 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.436 ' HB2' ' HG3' ' B' ' 15' ' ' LYS . 6.4 tttm -82.82 -32.83 27.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.766 -0.584 . . . . 0.0 109.823 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.655 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.2 OUTLIER -144.26 174.42 10.91 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.625 0.726 . . . . 0.0 110.38 -179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.502 ' HA ' HG22 ' B' ' 12' ' ' ILE . 18.7 mm -131.05 121.15 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 11' ' ' ALA . 14.8 mt -87.85 -47.41 8.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -162.17 -152.91 0.25 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.628 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -80.82 1.78 29.15 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.851 -1.155 . . . . 0.0 111.002 -179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 1.9 m-80 -134.17 -41.71 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.364 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.676 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -93.33 139.98 30.06 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.659 HG12 HG21 ' B' ' 28' ' ' ILE . 4.6 pt -149.05 147.27 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' B' ' 22' ' ' ILE . 20.6 t -89.26 107.8 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' B' ' 21' ' ' LYS . 28.8 m -101.49 -176.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.769 -0.582 . . . . 0.0 109.708 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -144.18 125.97 15.21 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.558 -0.713 . . . . 0.0 109.402 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.433 ' HB2' ' HG3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -112.4 -176.74 2.99 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.348 0.594 . . . . 0.0 109.825 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -43.4 94.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 109.983 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.23 -53.05 60.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.927 -0.483 . . . . 0.0 110.315 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 179.12 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.603 -0.686 . . . . 0.0 109.455 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -68.87 144.49 54.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.448 -0.783 . . . . 0.0 109.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' B' ' 14' ' ' VAL . 8.5 mtmt -130.84 175.59 8.92 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.498 0.665 . . . . 0.0 109.581 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' B' ' 13' ' ' VAL . 16.2 mm -134.31 123.8 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.718 HD11 HG13 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -105.89 108.4 19.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.452 -0.78 . . . . 0.0 110.132 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' B' ' 44' ' ' GLU . 20.2 mt -102.27 105.43 16.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -144.38 120.88 1.5 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.56 0.14 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.752 0.787 . . . . 0.0 110.365 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.35 8.95 58.33 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.659 HG21 HG12 ' B' ' 12' ' ' ILE . 0.4 OUTLIER -57.72 -47.29 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.976 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.38 -37.88 79.05 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -71.21 143.59 50.4 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t30 71.58 26.56 3.14 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.74 -0.6 . . . . 0.0 110.324 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -169.19 174.82 5.97 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.456 -0.778 . . . . 0.0 109.945 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' O ' HD12 ' B' ' 3' ' ' ILE . 60.3 pttt -152.86 174.51 14.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.357 -0.839 . . . . 0.0 110.424 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.2 tmtt? -61.41 132.24 52.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.716 -0.615 . . . . 0.0 110.058 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 1.3 t-20 83.55 -10.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.603 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.1 151.33 24.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.127 -0.983 . . . . 0.0 108.852 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' B' ' 32' ' ' LYS . 32.7 mm -63.38 146.87 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.699 HG21 ' HG ' ' B' ' 23' ' ' LEU . 7.3 p -79.09 136.88 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.614 -0.679 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.76 124.43 90.73 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.589 ' HA ' HD13 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -70.17 -34.0 14.0 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.33 2.02 . . . . 0.0 110.929 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -27.93 69.6 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 28' ' ' ILE . 3.4 mttt -87.04 -18.81 29.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.802 -0.561 . . . . 0.0 110.076 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.718 HG13 HD11 ' B' ' 23' ' ' LEU . 1.2 mp -55.17 116.19 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.452 -0.78 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.665 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 6.3 mt-10 -116.76 -29.46 6.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -158.66 122.61 3.97 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.618 -0.676 . . . . 0.0 109.98 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.4 m -105.73 124.4 49.49 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.61 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.4 m-85 -118.59 144.39 46.15 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.476 0.655 . . . . 0.0 110.384 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.858 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -131.39 137.08 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -64.47 140.59 58.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.624 -0.672 . . . . 0.0 109.7 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -60.76 110.66 1.37 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.53 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.68 -0.637 . . . . 0.0 109.473 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 13.9 p -142.39 148.65 48.29 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.807 -0.558 . . . . 0.0 109.636 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.13 -69.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.79 2.327 . . . . 0.0 110.842 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.21 -38.92 2.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.573 -0.704 . . . . 0.0 110.205 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.804 -1.094 . . . . 0.0 110.134 -179.584 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.16 0.505 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -145.48 177.47 8.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.76 -0.587 . . . . 0.0 109.547 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 33' ' ' LYS . 2.1 mp -95.27 105.32 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.491 0.662 . . . . 0.0 109.242 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -89.19 -42.82 11.43 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.2 mtm180 -146.76 172.8 13.08 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.319 0.581 . . . . 0.0 110.004 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' A' ' 12' ' ' ILE . 20.4 mt -126.82 120.61 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.558 -0.713 . . . . 0.0 109.149 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' B' ' 11' ' ' ALA . 10.9 mt -87.59 -47.47 8.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -166.54 -157.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 2.4 t-80 -75.27 -8.5 56.79 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.908 -1.12 . . . . 0.0 111.394 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.43 -32.11 2.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.892 . . . . 0.0 110.846 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.736 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -102.12 140.62 36.16 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 121.352 -0.842 . . . . 0.0 110.365 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 5' ' ' ARG . 0.4 OUTLIER -153.67 143.0 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.812 ' HA ' HD13 ' A' ' 22' ' ' ILE . 12.5 t -87.32 113.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 21' ' ' LYS . 28.8 m -104.52 173.56 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.507 0.67 . . . . 0.0 109.958 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.37 124.32 18.72 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.534 0.683 . . . . 0.0 109.465 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.33 164.94 12.94 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -41.42 59.66 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -63.72 -51.45 64.94 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.313 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' OE1' HG22 ' A' ' 48' ' ' ILE . 1.8 pt-20 179.8 -170.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.454 -0.779 . . . . 0.0 109.906 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -72.59 142.84 48.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.641 -0.662 . . . . 0.0 110.335 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.976 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.1 mtpp -132.61 176.09 8.75 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.571 0.7 . . . . 0.0 109.732 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.812 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.6 mm -133.71 125.07 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.971 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -104.58 115.27 30.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD11 HG13 ' B' ' 22' ' ' ILE . 17.7 mt -114.36 98.11 6.72 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.713 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -141.4 125.88 2.89 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.46 104.12 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.709 0.766 . . . . 0.0 109.849 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 11.08 41.99 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -58.68 -45.28 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.642 -0.916 . . . . 0.0 109.039 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 9' ' ' HIS . . . -55.03 -38.83 68.46 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -69.16 134.28 49.08 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.68 39.1 0.9 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HD2' HG23 ' A' ' 38' ' ' VAL . 5.7 mtpt -158.43 156.56 30.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -160.82 169.83 21.92 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.63 -0.669 . . . . 0.0 109.697 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.66 32.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.467 -0.771 . . . . 0.0 109.478 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.2 OUTLIER 71.9 11.19 6.21 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.634 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.04 1.41 36.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.515 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 1' ' ' MET . 46.7 mt 67.2 153.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.459 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.971 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.7 p -82.74 136.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.0 110.419 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.485 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.2 t70 -72.14 128.88 88.49 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.768 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.7 Cg_endo -70.74 -36.16 8.64 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.367 2.045 . . . . 0.0 111.134 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -26.34 68.78 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.86 -20.29 22.44 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.817 -0.552 . . . . 0.0 110.14 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.778 HG23 HD11 ' A' ' 23' ' ' LEU . 62.7 mt -59.75 108.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.422 -0.799 . . . . 0.0 109.802 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.713 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 8.1 mt-10 -103.04 -31.53 10.15 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.85 121.37 9.12 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.682 -0.636 . . . . 0.0 110.011 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -103.8 121.82 43.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.617 -0.677 . . . . 0.0 109.302 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 12.1 m-85 -114.92 146.95 40.6 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.35 0.595 . . . . 0.0 109.914 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.976 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -135.42 131.43 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 7.6 ptt85 -74.1 127.27 32.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.858 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 112.77 2.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.797 -0.564 . . . . 0.0 109.521 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.48 -60.82 2.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.688 -0.632 . . . . 0.0 109.499 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 6.0 t -168.11 142.69 2.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.776 -0.578 . . . . 0.0 109.584 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 36.5 Cg_endo -78.3 -97.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.533 2.155 . . . . 0.0 109.715 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.85 -2.75 1.33 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.442 -0.786 . . . . 0.0 111.406 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 109.732 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.555 ' O ' HG23 ' B' ' 37' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.125 0.488 . . . . 0.0 109.708 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.1 OUTLIER -145.38 177.41 8.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.593 . . . . 0.0 109.563 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.494 HD13 ' O ' ' B' ' 33' ' ' LYS . 2.1 mp -95.26 105.28 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.662 . . . . 0.0 109.242 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -89.16 -42.91 11.39 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 14.3 mtm180 -146.66 172.83 13.0 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.318 0.58 . . . . 0.0 110.013 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.596 ' HA ' HG13 ' B' ' 12' ' ' ILE . 20.5 mt -126.81 120.62 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.736 HD22 ' CB ' ' A' ' 11' ' ' ALA . 11.1 mt -87.69 -47.46 8.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -166.61 -157.36 0.27 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.496 ' HA ' ' CB ' ' B' ' 29' ' ' ALA . 2.4 t-80 -75.06 -8.42 56.48 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.924 -1.11 . . . . 0.0 111.388 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -126.49 -32.16 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.843 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.722 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -102.07 140.72 35.98 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.375 -0.828 . . . . 0.0 110.441 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.616 HG23 ' O ' ' B' ' 5' ' ' ARG . 0.4 OUTLIER -153.73 142.88 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.8 ' HA ' HD13 ' B' ' 22' ' ' ILE . 12.3 t -87.23 113.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' B' ' 21' ' ' LYS . 30.6 m -104.72 173.43 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.473 0.654 . . . . 0.0 109.966 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 124.41 19.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.486 0.66 . . . . 0.0 109.461 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -113.36 164.97 12.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 109.654 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -63.64 -51.45 65.14 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.545 ' OE1' HG22 ' B' ' 48' ' ' ILE . 1.7 pt-20 179.52 -171.23 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.52 -0.737 . . . . 0.0 109.838 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -71.95 142.92 49.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.631 -0.668 . . . . 0.0 110.348 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.972 ' HG3' HG23 ' B' ' 48' ' ' ILE . 1.1 mtpp -132.78 175.87 8.96 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.748 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' B' ' 13' ' ' VAL . 12.7 mm -133.59 125.3 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.974 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -104.69 115.16 29.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.898 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.2 mt -114.19 97.95 6.66 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.712 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -141.29 125.76 2.87 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.43 104.0 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.739 0.781 . . . . 0.0 109.845 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.74 10.89 42.24 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.439 ' HA ' HD13 ' B' ' 28' ' ' ILE . 0.4 OUTLIER -58.53 -45.29 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.677 -0.896 . . . . 0.0 109.08 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' B' ' 9' ' ' HIS . . . -54.93 -38.95 68.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -69.17 134.45 49.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 71.54 38.52 0.99 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.696 ' HD2' HG23 ' B' ' 38' ' ' VAL . 6.3 mtpt -157.32 157.4 34.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.836 -0.54 . . . . 0.0 109.858 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.494 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.6 OUTLIER -161.38 168.78 23.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.573 -0.704 . . . . 0.0 109.811 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.97 127.43 31.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 72.08 10.97 6.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.679 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' B' ' 37' ' ' ILE . 0.6 OUTLIER -102.04 1.58 36.63 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.172 -0.955 . . . . 0.0 110.496 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.555 HG23 ' O ' ' B' ' 1' ' ' MET . 46.8 mt 67.16 153.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.546 -0.721 . . . . 0.0 110.497 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.974 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.9 p -82.85 136.12 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.0 110.383 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.3 t70 -72.18 128.84 88.49 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.763 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.0 Cg_endo -70.6 -36.26 8.85 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.427 2.085 . . . . 0.0 111.148 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -62.88 -26.45 68.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.67 -20.3 22.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.842 -0.536 . . . . 0.0 110.193 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.769 HG23 HD11 ' B' ' 23' ' ' LEU . 63.3 mt -59.72 108.82 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.438 -0.789 . . . . 0.0 109.838 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.712 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 8.1 mt-10 -103.27 -31.55 10.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.64 121.23 9.16 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.716 -0.615 . . . . 0.0 110.014 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.4 m -103.94 121.36 42.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.665 -0.647 . . . . 0.0 109.364 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.645 ' HB2' ' HB ' ' B' ' 22' ' ' ILE . 12.5 m-85 -114.39 147.4 39.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.684 -0.635 . . . . 0.0 109.869 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.972 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -135.33 132.14 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 109.434 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -72.99 126.48 30.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 109.702 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -64.52 112.65 3.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.498 -0.752 . . . . 0.0 109.259 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.88 -60.16 2.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.736 -0.602 . . . . 0.0 109.659 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.9 t -168.43 143.19 2.79 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.708 -0.62 . . . . 0.0 109.796 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.5 -97.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.626 2.218 . . . . 0.0 109.627 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.82 -2.78 1.31 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.339 -0.851 . . . . 0.0 111.371 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.655 ' O ' HG23 ' A' ' 37' ' ' ILE . 22.1 mtp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.092 0.472 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -149.87 149.59 30.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.77 106.88 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.368 0.604 . . . . 0.0 109.887 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HD3' ' HG3' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -88.37 -35.35 17.2 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 82.2 mtm-85 -140.78 169.99 16.59 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.462 0.649 . . . . 0.0 110.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -128.56 124.47 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 10.7 mt -89.81 -46.94 8.23 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 10.8 p30 -167.89 -167.13 0.81 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.497 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 31.8 t60 -57.05 -26.21 59.95 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.428 -0.795 . . . . 0.0 111.818 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.64 -28.97 5.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 111.618 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -97.47 140.34 32.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 111.027 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 28' ' ' ILE . 3.0 pt -152.75 152.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 4.2 t -101.24 119.89 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.41 142.41 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.577 -0.702 . . . . 0.0 109.583 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 5.4 ptpt -87.67 151.17 23.15 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 0.0 109.497 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.74 -175.41 4.28 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.384 0.611 . . . . 0.0 110.409 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.12 -46.65 75.61 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.832 -0.543 . . . . 0.0 110.068 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.07 -54.35 45.83 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.523 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -75.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.718 -0.614 . . . . 0.0 109.589 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.0 tt0 -148.96 147.44 28.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -150.13 139.39 21.28 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.577 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.4 mp -92.64 128.91 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.81 27.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.856 -0.527 . . . . 0.0 109.79 -179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 48.1 mt -99.15 104.09 16.04 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -137.1 123.6 2.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.01 101.76 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.653 0.74 . . . . 0.0 110.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.58 9.8 61.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG21 HG12 ' A' ' 12' ' ' ILE . 1.1 tt -61.8 -38.73 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-N 118.456 1.128 . . . . 0.0 109.377 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.65 89.96 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.497 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 38.3 t80 -70.1 144.62 52.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.9 t-20 67.48 25.45 8.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.858 -0.526 . . . . 0.0 109.717 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 37' ' ' ILE . 9.4 mmtt -149.63 173.35 13.76 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 0.0 109.823 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 36' ' ' ASP . 8.1 ptpt -165.34 -175.85 3.78 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.517 -0.739 . . . . 0.0 109.653 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.96 130.28 44.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.342 -0.848 . . . . 0.0 110.491 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 65.48 17.31 10.9 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.981 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 1.4 t70 -90.89 0.66 57.44 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 1' ' ' MET . 5.3 mt 69.73 139.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 121.453 0.645 . . . . 0.0 109.548 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.8 p -73.63 133.07 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.546 -0.722 . . . . 0.0 110.114 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.2 t70 -68.63 129.14 92.75 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.773 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.4 Cg_endo -71.16 -38.27 5.09 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.444 2.096 . . . . 0.0 110.756 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.16 -28.23 69.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.0 -23.19 25.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.807 -0.558 . . . . 0.0 109.985 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.79 HG23 HD11 ' A' ' 23' ' ' LEU . 41.6 mt -53.83 109.75 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.579 -0.701 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.7 mt-10 -113.92 -28.22 7.46 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -149.81 114.67 5.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.627 -0.671 . . . . 0.0 109.667 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.4 m -102.05 117.5 34.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.562 -0.711 . . . . 0.0 109.586 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.3 m-85 -117.85 139.7 50.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.714 -0.617 . . . . 0.0 109.747 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.18 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.685 -0.634 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.21 135.0 57.6 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.348 0.594 . . . . 0.0 110.072 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -70.43 118.65 13.51 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.66 -0.65 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.95 -59.28 3.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.74 -0.6 . . . . 0.0 109.815 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 43.4 79.28 0.34 Allowed Pre-proline 0 N--CA 1.506 2.335 0 CA-C-O 120.972 0.415 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -78.47 -71.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 123.131 2.554 . . . . 0.0 110.781 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.45 -33.3 28.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.639 -0.663 . . . . 0.0 109.653 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.702 -179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.649 ' O ' HG23 ' B' ' 37' ' ' ILE . 22.7 mtp . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.0 OUTLIER -149.94 149.85 31.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.683 HD11 ' HG2' ' B' ' 32' ' ' LYS . 3.1 mt -80.81 107.23 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.39 0.614 . . . . 0.0 109.878 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.427 ' HD3' ' HG3' ' B' ' 5' ' ' ARG . 0.1 OUTLIER -88.53 -35.3 17.03 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.723 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 82.1 mtm-85 -140.98 170.01 16.55 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.079 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -128.5 124.66 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 11' ' ' ALA . 10.9 mt -89.96 -46.93 8.19 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -167.9 -167.04 0.79 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 31.6 t60 -57.04 -26.33 60.13 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.453 -0.779 . . . . 0.0 111.799 -178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.5 -29.07 5.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.255 -0.903 . . . . 0.0 111.704 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -97.46 140.4 31.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.042 -1.037 . . . . 0.0 110.996 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.522 HG12 HG21 ' B' ' 28' ' ' ILE . 3.0 pt -152.73 152.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.723 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.4 t -101.35 119.74 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.31 142.47 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.646 -0.659 . . . . 0.0 109.623 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 5.5 ptpt -87.59 151.23 23.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.68 -0.637 . . . . 0.0 109.589 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.84 -175.38 4.28 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.382 0.611 . . . . 0.0 110.337 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -55.09 -46.62 75.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.852 -0.53 . . . . 0.0 110.119 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -61.16 -54.36 45.43 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -75.43 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.796 -0.565 . . . . 0.0 109.617 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 15.0 tt0 -148.94 147.38 28.57 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.348 0.594 . . . . 0.0 110.357 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.508 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -150.16 139.33 21.19 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.578 ' CD1' HG13 ' B' ' 13' ' ' VAL . 1.4 mp -92.63 128.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -102.48 113.84 27.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.83 -0.544 . . . . 0.0 109.806 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 47.6 mt -99.01 104.21 16.23 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -137.24 123.66 2.85 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.95 101.77 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.921 -0.753 . . . . 0.0 110.542 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.31 10.34 60.9 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.522 HG21 HG12 ' B' ' 12' ' ' ILE . 1.1 tt -62.09 -38.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.306 -1.114 . . . . 0.0 109.396 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.89 -38.75 92.16 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 38.7 t80 -69.81 144.64 52.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 66.74 29.78 8.4 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.346 0.594 . . . . 0.0 109.482 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.683 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -156.51 170.66 21.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.607 -0.683 . . . . 0.0 109.845 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' B' ' 36' ' ' ASP . 7.1 ptpt -162.78 -174.09 3.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.499 -0.75 . . . . 0.0 109.95 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.22 130.43 44.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.403 -0.81 . . . . 0.0 110.548 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 65.4 16.81 10.71 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.983 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' B' ' 33' ' ' LYS . 1.1 t70 -90.99 0.79 57.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.302 -0.874 . . . . 0.0 110.415 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.649 HG23 ' O ' ' B' ' 1' ' ' MET . 5.1 mt 69.9 139.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.451 0.643 . . . . 0.0 109.793 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.868 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.27 133.34 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.599 -0.688 . . . . 0.0 109.949 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.463 ' O ' HG13 ' B' ' 43' ' ' ILE . 16.8 t70 -68.88 129.16 92.53 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.745 ' HA ' HD12 ' B' ' 43' ' ' ILE . 30.9 Cg_endo -71.23 -38.15 5.14 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.356 2.038 . . . . 0.0 110.676 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -63.3 -28.19 69.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -87.03 -23.17 25.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.821 -0.549 . . . . 0.0 109.995 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.811 HG23 HD11 ' B' ' 23' ' ' LEU . 41.1 mt -53.8 109.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.502 -0.749 . . . . 0.0 109.685 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.446 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -113.91 -28.17 7.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.582 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 0.7 OUTLIER -149.84 114.67 5.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.533 -0.729 . . . . 0.0 109.678 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -102.2 117.41 34.71 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.0 109.566 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.575 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.3 m-85 -117.71 139.77 50.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.817 -0.552 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.508 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.4 OUTLIER -127.42 145.19 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.714 -0.616 . . . . 0.0 109.679 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.18 135.05 57.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.725 -0.609 . . . . 0.0 110.014 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -70.41 118.59 13.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.91 -59.27 3.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.664 -0.647 . . . . 0.0 109.768 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 43.43 79.26 0.34 Allowed Pre-proline 0 N--CA 1.505 2.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.3 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -78.45 -71.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.113 2.542 . . . . 0.0 110.838 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.56 -33.17 28.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.669 -0.645 . . . . 0.0 109.628 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.709 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' HG12 ' A' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.577 0.703 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -96.91 166.72 11.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.517 0.675 . . . . 0.0 110.011 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.4 mp -81.2 101.31 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.594 0.712 . . . . 0.0 109.503 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.25 -37.51 45.03 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.664 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -149.29 175.34 11.5 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.44 0.638 . . . . 0.0 109.681 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' HG13 ' A' ' 12' ' ' ILE . 3.5 mp -128.51 125.79 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.565 -0.709 . . . . 0.0 109.428 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 11' ' ' ALA . 9.4 mt -94.53 -48.05 6.28 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.6 p30 -167.55 -161.87 0.42 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -67.92 -18.06 64.65 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.108 -0.995 . . . . 0.0 111.637 -178.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.86 -31.55 4.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 111.11 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.83 138.33 37.06 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.339 -0.851 . . . . 0.0 110.383 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD11 ' HB2' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -151.02 143.73 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 11.1 t -87.1 118.05 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -117.09 147.99 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.411 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.87 143.73 32.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.603 0.716 . . . . 0.0 109.883 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.03 -176.16 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.21 0.529 . . . . 0.0 109.649 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.25 92.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.636 . . . . 0.0 110.456 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -52.18 61.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.843 -0.536 . . . . 0.0 110.718 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.99 -148.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.736 . . . . 0.0 109.572 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.44 30.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 110.054 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.589 ' HE3' HG23 ' A' ' 46' ' ' THR . 11.2 ttpt -147.23 178.96 7.98 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.676 0.751 . . . . 0.0 109.858 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.621 HD12 HD11 ' A' ' 7' ' ' LEU . 18.8 mm -141.08 118.66 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.869 HD11 HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.72 112.52 25.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.67 -0.644 . . . . 0.0 109.668 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 13.8 mt -108.1 93.68 4.66 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.9 124.66 4.05 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.8 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.751 0.786 . . . . 0.0 110.564 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.03 9.69 53.49 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -62.63 -38.43 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 118.637 1.218 . . . . 0.0 109.262 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.725 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -58.91 -39.47 81.62 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.6 139.06 55.52 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.42 31.52 1.78 Allowed 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.319 0.581 . . . . 0.0 109.855 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -156.56 161.25 39.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.0 110.112 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -153.94 176.79 11.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.637 -0.664 . . . . 0.0 109.88 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 tptp -60.06 132.46 54.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.301 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.53 3.44 3.08 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.322 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.725 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.7 m-20 -92.94 148.41 22.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.221 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.4 mm -72.28 144.33 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 0.0 109.35 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 23' ' ' LEU . 12.6 p -78.77 130.76 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.397 0.617 . . . . 0.0 109.832 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 43' ' ' ILE . 25.7 t70 -68.86 129.97 91.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.02 -35.36 9.08 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.397 2.065 . . . . 0.0 110.989 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -31.02 70.26 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -84.34 -26.98 28.06 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.869 HG23 HD11 ' A' ' 23' ' ' LEU . 66.8 mt -56.7 109.04 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.581 -0.699 . . . . 0.0 109.453 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.0 mt-10 -107.11 -31.45 8.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 19.1 mmtm -144.58 128.38 17.31 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.702 -0.624 . . . . 0.0 109.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HE3' ' A' ' 21' ' ' LYS . 36.5 m -111.14 121.54 45.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.595 -0.691 . . . . 0.0 109.255 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.2 m-85 -123.82 131.3 53.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 110.226 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.537 HG23 ' HG3' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -123.15 145.82 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -58.04 108.72 0.63 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.661 -0.65 . . . . 0.0 109.613 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HB3' HD12 ' B' ' 48' ' ' ILE . 0.4 OUTLIER -118.58 129.39 55.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.748 -179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.68 -62.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.69 -0.631 . . . . 0.0 109.472 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.9 p -145.46 139.77 15.24 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.742 -0.599 . . . . 0.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 -66.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.751 2.3 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -125.78 -54.07 1.54 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 0.0 109.732 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.612 -179.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.456 ' HB3' HG12 ' B' ' 38' ' ' VAL . 12.7 mtp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.624 0.726 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -97.15 166.73 11.44 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.036 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.727 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.4 mp -81.1 101.17 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.625 0.726 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -78.22 -37.8 44.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -149.18 174.22 12.59 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.366 0.603 . . . . 0.0 109.663 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.749 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.6 mp -127.22 125.72 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.623 -0.673 . . . . 0.0 109.407 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.614 HD11 HD12 ' B' ' 22' ' ' ILE . 9.7 mt -94.38 -48.51 6.11 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.5 p30 -167.57 -162.04 0.43 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.4 OUTLIER -67.56 -18.24 64.94 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.027 -1.046 . . . . 0.0 111.581 -178.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -118.89 -31.72 4.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 111.108 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.647 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -98.05 134.69 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.339 -0.85 . . . . 0.0 110.167 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.749 ' CD1' HG23 ' B' ' 6' ' ' ILE . 35.5 mm -144.94 140.61 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 13.6 t -86.83 116.63 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -116.35 149.08 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.476 -0.765 . . . . 0.0 109.656 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 143.91 33.32 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.612 0.72 . . . . 0.0 109.872 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -130.18 -176.28 3.9 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.229 0.537 . . . . 0.0 109.664 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.34 -45.33 91.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.719 -0.613 . . . . 0.0 110.511 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.66 -52.05 62.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 177.87 -148.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.48 -0.763 . . . . 0.0 109.479 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.72 160.48 30.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.272 -0.892 . . . . 0.0 109.996 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' B' ' 46' ' ' THR . 11.3 ttpt -147.25 179.06 7.91 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.643 0.735 . . . . 0.0 109.867 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.614 HD12 HD11 ' B' ' 7' ' ' LEU . 18.6 mm -141.23 118.53 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.887 HD11 HG23 ' B' ' 43' ' ' ILE . 0.0 OUTLIER -103.67 112.11 24.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.58 -0.7 . . . . 0.0 109.685 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.9 mt -107.7 93.81 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -131.96 124.66 4.04 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.934 -0.745 . . . . 0.0 110.605 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 9.71 54.16 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA3' ' B' ' 25' ' ' GLY . 0.5 OUTLIER -62.77 -38.86 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 118.611 1.206 . . . . 0.0 109.271 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -58.98 -38.56 79.43 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -69.22 139.52 54.49 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.27 31.18 1.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.282 0.563 . . . . 0.0 109.739 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.692 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -156.23 161.4 40.27 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 110.075 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.598 ' O ' HD13 ' B' ' 3' ' ' ILE . 0.8 OUTLIER -153.9 176.86 11.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.58 -0.7 . . . . 0.0 109.923 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 16.2 tptp -60.21 132.42 53.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.396 -0.815 . . . . 0.0 110.26 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 77.66 3.33 3.02 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.291 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.727 ' O ' HD12 ' B' ' 3' ' ' ILE . 2.7 m-20 -92.91 148.46 21.99 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.064 -1.022 . . . . 0.0 109.234 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.8 mm -72.36 144.42 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 109.323 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.762 HG21 ' HG ' ' B' ' 23' ' ' LEU . 12.6 p -78.82 130.71 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 109.847 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.487 ' O ' HG13 ' B' ' 43' ' ' ILE . 25.8 t70 -68.82 129.95 92.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.774 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.3 Cg_endo -70.97 -35.36 9.2 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.386 2.057 . . . . 0.0 111.026 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -31.13 70.34 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -84.31 -26.91 28.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.869 -0.519 . . . . 0.0 109.629 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.887 HG23 HD11 ' B' ' 23' ' ' LEU . 66.6 mt -56.75 109.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.567 -0.708 . . . . 0.0 109.443 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.564 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 13.1 mt-10 -107.06 -31.44 8.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 19.1 mmtm -144.59 128.36 17.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.78 -0.575 . . . . 0.0 109.869 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.59 HG23 ' HE3' ' B' ' 21' ' ' LYS . 37.4 m -111.09 121.35 45.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.669 -0.644 . . . . 0.0 109.293 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.6 m-85 -123.64 131.29 53.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.511 HG23 ' HG3' ' B' ' 21' ' ' LYS . 0.6 OUTLIER -123.12 145.82 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -58.05 108.7 0.63 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.684 -0.635 . . . . 0.0 109.681 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -118.63 129.36 55.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.624 -0.672 . . . . 0.0 109.779 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -163.67 -62.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.676 -0.64 . . . . 0.0 109.516 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -145.47 139.83 15.3 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.727 -0.608 . . . . 0.0 109.59 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.37 -66.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.799 2.333 . . . . 0.0 110.805 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -125.76 -54.06 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.592 -0.692 . . . . 0.0 109.782 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 50.7 p90 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.667 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HE3' HG11 ' A' ' 38' ' ' VAL . 6.7 ttp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.327 0.584 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 169.16 8.69 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.606 0.717 . . . . 0.0 110.135 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.627 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.5 mp -89.75 108.54 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -82.89 -34.09 26.77 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 16.6 ttm105 -147.24 162.94 37.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.804 -0.56 . . . . 0.0 109.703 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.751 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.6 mp -123.31 121.7 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.658 -0.651 . . . . 0.0 109.553 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.778 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.8 mt -84.81 -48.53 9.28 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -157.45 -150.84 0.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -83.86 6.74 20.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.855 -1.153 . . . . 0.0 110.814 -179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 26' ' ' ALA . 2.0 m-80 -139.0 -43.61 0.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.689 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -90.41 136.89 32.77 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.602 -0.686 . . . . 0.0 110.071 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.751 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.4 pt -150.94 144.38 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' ' HB3' ' A' ' 5' ' ' ARG . 11.3 t -87.56 107.38 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 108.745 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 3' ' ' ILE . 33.6 m -107.46 170.75 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.3 mtpt -125.35 154.5 41.73 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.788 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.51 -179.88 6.7 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.238 0.542 . . . . 0.0 109.583 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.71 -44.79 77.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.523 -0.736 . . . . 0.0 109.928 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -65.53 -53.12 46.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.922 -0.486 . . . . 0.0 110.27 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.71 -163.87 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.571 -0.706 . . . . 0.0 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.7 tt0 -73.47 145.49 45.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.6 -0.687 . . . . 0.0 109.876 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' HG23 ' A' ' 14' ' ' VAL . 3.2 ptpt -146.42 142.39 28.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.738 -0.601 . . . . 0.0 109.784 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 7' ' ' LEU . 30.0 mm -84.27 131.55 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' A' ' 38' ' ' VAL . 2.6 tp -111.37 106.65 15.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.805 -0.559 . . . . 0.0 109.697 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 9.5 mt -101.18 116.16 32.16 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.673 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -155.82 121.5 1.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . . . -54.64 105.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.761 -0.847 . . . . 0.0 110.43 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.83 1.49 57.37 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.634 HG21 HG12 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -56.08 -47.02 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.932 . . . . 0.0 109.409 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -59.28 -38.14 79.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 109.233 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -72.9 141.81 47.89 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 72.3 27.16 2.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.836 -0.54 . . . . 0.0 110.144 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.59 ' HD3' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.72 166.9 32.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.531 -0.73 . . . . 0.0 109.839 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -157.27 178.9 9.8 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.449 -0.782 . . . . 0.0 110.397 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 14.6 tptp -63.81 129.89 41.92 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.5 0.667 . . . . 0.0 109.932 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.94 1.93 3.88 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.035 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HD12 ' A' ' 3' ' ' ILE . 19.4 t70 -93.52 141.2 28.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 108.877 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.56 143.03 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.656 -0.652 . . . . 0.0 109.527 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.728 HG11 ' CD2' ' A' ' 23' ' ' LEU . 11.8 p -93.8 134.56 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 121.456 0.646 . . . . 0.0 110.12 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.0 t70 -66.75 135.82 94.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 43' ' ' ILE . 30.3 Cg_endo -70.37 -34.38 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.301 2.001 . . . . 0.0 110.868 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 t -62.48 -30.88 71.58 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.38 -21.46 42.31 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.913 -0.492 . . . . 0.0 109.729 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 40' ' ' PRO . 78.0 mt -73.8 105.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.427 -0.796 . . . . 0.0 109.52 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.673 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -88.44 -37.95 15.42 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 9.7 mtmm -140.02 154.52 47.15 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.41 0.624 . . . . 0.0 110.536 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.0 m -137.23 106.2 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 7.0 m-85 -104.74 147.54 27.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.655 -0.653 . . . . 0.0 109.89 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -135.02 137.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.661 -0.649 . . . . 0.0 109.358 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -57.85 139.29 54.49 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.668 -0.645 . . . . 0.0 110.176 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 112.97 1.87 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.35 -43.57 69.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.744 -0.597 . . . . 0.0 109.809 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 25.0 p -69.74 146.63 95.85 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 33.8 Cg_endo -76.82 -64.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.842 2.362 . . . . 0.0 110.628 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -109.31 -53.5 2.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.748 -0.595 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.667 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.434 ' HE3' HG11 ' B' ' 38' ' ' VAL . 6.3 ttp . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.306 0.574 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 169.6 8.43 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.645 0.736 . . . . 0.0 110.132 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' B' ' 14' ' ' VAL . 3.5 mp -90.12 108.37 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.447 0.641 . . . . 0.0 109.463 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -82.69 -34.27 27.39 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.649 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 16.4 ttm105 -147.33 162.85 38.13 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.32 0.581 . . . . 0.0 109.698 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.6 mp -123.13 121.74 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.635 -0.665 . . . . 0.0 109.522 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.9 mt -84.73 -48.15 9.72 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -158.18 -151.4 0.29 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.2 OUTLIER -83.22 5.49 22.75 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.834 -1.166 . . . . 0.0 110.712 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 25' ' ' GLY . 2.3 m-80 -137.0 -43.93 0.57 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.884 . . . . 0.0 110.408 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -90.52 138.44 31.56 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.641 -0.662 . . . . 0.0 110.222 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.762 HG22 ' HA ' ' B' ' 6' ' ' ILE . 2.8 pt -151.89 143.78 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' B' ' 5' ' ' ARG . 11.4 t -87.0 107.62 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.666 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' B' ' 3' ' ' ILE . 33.2 m -107.33 171.07 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.635 -0.665 . . . . 0.0 109.768 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 34.8 mtpt -125.73 154.53 42.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.658 -0.652 . . . . 0.0 109.653 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.76 -179.96 6.78 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.215 0.531 . . . . 0.0 109.604 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -55.57 -44.86 77.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 109.907 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -65.5 -53.24 45.27 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.237 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.89 -164.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.627 -0.671 . . . . 0.0 109.621 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 7.0 tt0 -73.64 145.34 45.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.598 -0.689 . . . . 0.0 109.888 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.473 ' HB3' HG23 ' B' ' 48' ' ' ILE . 2.9 ptpt -146.49 142.32 27.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.718 -0.614 . . . . 0.0 109.817 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.629 ' CD1' HG22 ' B' ' 13' ' ' VAL . 26.2 mm -83.77 131.26 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.738 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.9 tp -111.28 106.84 15.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.693 -0.629 . . . . 0.0 109.725 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 22' ' ' ILE . 10.7 mt -100.21 112.81 25.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -149.92 119.66 1.06 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.29 102.72 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.906 -0.761 . . . . 0.0 110.422 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.64 1.69 57.58 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.587 HG13 ' HB3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -59.81 -39.38 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 118.664 1.232 . . . . 0.0 109.585 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -60.25 -37.1 79.37 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -74.39 142.36 45.03 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.79 27.32 2.87 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.279 0.561 . . . . 0.0 109.975 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD3' HG23 ' B' ' 38' ' ' VAL . 0.2 OUTLIER -155.46 165.66 35.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 0.0 109.725 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' B' ' 36' ' ' ASP . 0.9 OUTLIER -155.8 179.54 9.1 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.446 -0.784 . . . . 0.0 110.272 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.77 130.68 44.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.592 -0.692 . . . . 0.0 110.146 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.77 1.85 3.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.553 ' O ' HD12 ' B' ' 3' ' ' ILE . 18.9 t70 -93.7 141.53 28.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 108.768 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -66.87 142.9 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.538 0.685 . . . . 0.0 109.6 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.738 HG11 ' CD2' ' B' ' 23' ' ' LEU . 11.3 p -93.68 134.43 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.435 0.636 . . . . 0.0 110.033 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.456 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.1 t70 -66.94 135.29 94.09 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.841 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.7 Cg_endo -70.69 -33.65 12.71 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.227 1.951 . . . . 0.0 110.905 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 2.1 t -62.16 -30.82 71.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG13 ' B' ' 28' ' ' ILE . 0.8 OUTLIER -81.15 -20.39 41.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.807 -0.558 . . . . 0.0 109.731 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.841 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.3 mt -74.49 105.38 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.642 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 0.7 OUTLIER -88.4 -37.58 15.76 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 9.7 mtmm -140.26 154.55 46.89 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -137.2 106.59 6.09 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 7.5 m-85 -105.68 147.0 29.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.702 . . . . 0.0 109.953 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.2 OUTLIER -134.87 137.85 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 0.0 109.423 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -57.63 138.37 55.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.682 -0.636 . . . . 0.0 109.738 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 ttpp -60.62 114.44 2.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.691 -0.631 . . . . 0.0 109.667 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -69.35 -42.56 75.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.879 -0.513 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 24.2 p -68.89 145.97 97.1 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.726 -0.609 . . . . 0.0 109.828 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.13 -64.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.795 2.33 . . . . 0.0 110.633 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -109.28 -53.53 2.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.771 -0.58 . . . . 0.0 109.542 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.734 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -141.93 160.78 39.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.71 -0.619 . . . . 0.0 109.489 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.4 mp -82.42 105.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.585 0.707 . . . . 0.0 109.937 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 8.2 tmtm? -84.16 -38.59 20.47 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 14.0 mtt180 -143.74 173.1 11.97 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.392 0.615 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.515 HD13 ' C ' ' A' ' 5' ' ' ARG . 2.4 mm -123.24 121.34 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.676 -0.64 . . . . 0.0 109.7 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 22' ' ' ILE . 11.1 mt -90.8 -47.37 7.66 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 14.4 p30 -171.48 -162.62 0.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -66.32 -27.63 68.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.014 -1.054 . . . . 0.0 111.341 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.04 -22.45 11.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -0.827 . . . . 0.0 111.401 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' B' ' 7' ' ' LEU . . . -109.71 143.18 39.85 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.092 -1.005 . . . . 0.0 110.786 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.3 OUTLIER -156.06 144.51 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.697 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 5.0 t -89.5 116.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 21' ' ' LYS . 35.6 m -116.05 171.36 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.655 -0.653 . . . . 0.0 110.002 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 29.1 mtmm -114.95 168.55 9.81 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.479 0.657 . . . . 0.0 109.712 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -159.16 161.09 36.2 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.2 -42.53 51.61 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.808 -0.557 . . . . 0.0 109.546 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -68.62 -49.92 55.49 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.35 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.4 pt-20 175.18 -174.74 0.09 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 22.3 tt0 -69.4 136.85 52.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.585 -0.697 . . . . 0.0 109.403 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.683 ' HB3' HG23 ' A' ' 48' ' ' ILE . 4.0 ptpt -132.8 142.86 49.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.781 -0.575 . . . . 0.0 109.915 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.747 HD12 HD11 ' A' ' 7' ' ' LEU . 22.2 mm -90.19 125.43 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HG11 ' A' ' 38' ' ' VAL . 1.1 mp -103.11 118.87 37.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.583 -0.698 . . . . 0.0 109.857 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.74 103.02 9.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.82 124.77 2.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.24 102.09 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.899 -0.765 . . . . 0.0 110.18 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.35 17.05 30.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.581 ' HA ' ' HD3' ' A' ' 42' ' ' LYS . 0.4 OUTLIER -66.37 -39.99 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.319 -1.107 . . . . 0.0 109.163 179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -61.55 -28.56 69.42 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 39.9 t80 -80.34 135.05 36.12 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.7 t-20 79.82 29.16 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.715 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -149.78 179.07 8.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.31 -0.869 . . . . 0.0 110.33 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.87 169.8 22.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.773 -0.579 . . . . 0.0 109.461 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -64.78 126.72 28.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.367 -0.833 . . . . 0.0 109.669 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 71.29 7.8 6.19 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.612 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.453 ' O ' HD12 ' A' ' 3' ' ' ILE . 20.5 t70 -89.94 155.93 18.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.845 . . . . 0.0 108.856 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 1' ' ' MET . 6.8 mm -74.39 135.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.442 -0.786 . . . . 0.0 109.363 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.804 HG11 ' CD2' ' A' ' 23' ' ' LEU . 13.5 p -89.36 134.89 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.533 0.682 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.567 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 6.8 t70 -71.42 138.75 83.86 Favored Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 43' ' ' ILE . 33.7 Cg_endo -72.39 -27.05 16.51 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.193 1.929 . . . . 0.0 111.07 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.86 -35.57 71.15 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.554 -0.716 . . . . 0.0 109.41 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 28' ' ' ILE . 1.8 ptpt -88.59 -22.37 23.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 0.0 110.042 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 40' ' ' PRO . 82.8 mt -64.99 109.95 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.481 -0.762 . . . . 0.0 109.097 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.559 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 17.5 mt-10 -100.71 -28.79 12.64 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -142.4 147.62 36.49 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.688 -0.632 . . . . 0.0 110.442 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 m -132.27 98.27 4.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 11.2 m-85 -95.02 153.51 17.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.692 -0.63 . . . . 0.0 109.759 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -144.02 131.83 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.5 -0.75 . . . . 0.0 109.149 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 3.4 ptt85 -69.15 116.09 9.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 110.074 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.22 109.86 13.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.46 -54.38 2.52 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.661 -0.65 . . . . 0.0 109.595 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.6 m -78.33 134.78 62.18 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.738 -0.601 . . . . 0.0 109.475 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.39 -70.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.831 2.354 . . . . 0.0 110.769 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -57.72 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.616 -0.677 . . . . 0.0 109.718 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 117.657 -1.163 . . . . 0.0 110.499 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' B' ' 37' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 35' ' ' ASN . 0.0 OUTLIER -141.81 160.67 39.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.712 -0.617 . . . . 0.0 109.569 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.49 ' HA ' HG12 ' B' ' 14' ' ' VAL . 2.5 mp -82.78 106.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.568 0.699 . . . . 0.0 109.947 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.476 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -85.09 -37.87 19.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.68 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 15.3 mtt180 -143.4 172.51 12.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.712 -0.617 . . . . 0.0 110.139 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.519 HD13 ' C ' ' B' ' 5' ' ' ARG . 2.4 mm -123.08 121.24 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.797 -0.565 . . . . 0.0 109.657 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.745 HD11 HD12 ' B' ' 22' ' ' ILE . 10.8 mt -90.57 -47.38 7.72 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 14.4 p30 -171.62 -162.67 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -66.29 -27.59 68.04 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.09 -1.006 . . . . 0.0 111.365 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -110.13 -22.59 11.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 0.0 111.352 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.494 ' CB ' HD22 ' A' ' 7' ' ' LEU . . . -109.66 143.14 39.82 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.162 -0.961 . . . . 0.0 110.791 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.577 ' N ' HD12 ' B' ' 7' ' ' LEU . 0.3 OUTLIER -155.96 144.56 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 4.9 t -89.65 116.48 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' B' ' 21' ' ' LYS . 35.6 m -115.9 171.45 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.628 -0.67 . . . . 0.0 109.993 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HG3' ' B' ' 4' ' ' LYS . 28.7 mtmm -114.86 168.77 9.6 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.571 0.7 . . . . 0.0 109.659 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -159.38 160.99 35.58 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -50.25 -42.42 51.89 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -68.72 -49.79 56.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.376 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.1 pt-20 174.99 -174.71 0.08 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.467 -0.771 . . . . 0.0 109.472 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 22.4 tt0 -69.41 136.75 52.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.6 -0.688 . . . . 0.0 109.374 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.679 ' HB3' HG23 ' B' ' 48' ' ' ILE . 4.0 ptpt -132.77 142.87 49.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.731 -0.606 . . . . 0.0 109.887 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.745 HD12 HD11 ' B' ' 7' ' ' LEU . 22.3 mm -90.24 125.33 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.801 ' CD2' HG11 ' B' ' 38' ' ' VAL . 1.0 OUTLIER -103.06 118.89 37.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.606 -0.684 . . . . 0.0 109.951 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 13.0 mt -116.79 103.06 9.95 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -142.75 124.82 2.46 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.27 102.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.872 -0.781 . . . . 0.0 110.191 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.36 17.05 30.29 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.585 HG13 ' HD2' ' B' ' 42' ' ' LYS . 0.3 OUTLIER -66.29 -40.01 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.248 -1.148 . . . . 0.0 109.188 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -61.56 -28.62 69.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.466 ' O ' ' CB ' ' B' ' 31' ' ' ASN . 39.9 t80 -80.22 135.07 36.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.7 t-20 79.84 29.25 0.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.989 -0.444 . . . . 0.0 110.695 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -149.91 179.09 8.32 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.312 -0.867 . . . . 0.0 110.336 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.75 169.77 22.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.739 -0.601 . . . . 0.0 109.442 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -65.18 126.46 28.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.462 -0.774 . . . . 0.0 109.633 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.531 ' HA ' ' HB2' ' B' ' 2' ' ' LYS . 0.1 OUTLIER 71.83 7.66 5.92 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.497 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' ILE . 20.6 t70 -90.01 155.85 18.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 108.812 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' B' ' 1' ' ' MET . 6.9 mm -74.27 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.414 -0.804 . . . . 0.0 109.421 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.801 HG11 ' CD2' ' B' ' 23' ' ' LEU . 13.2 p -89.38 134.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.507 0.67 . . . . 0.0 110.022 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.569 ' HB3' ' HE3' ' B' ' 42' ' ' LYS . 6.8 t70 -71.39 138.77 83.94 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.924 ' HA ' HD12 ' B' ' 43' ' ' ILE . 33.5 Cg_endo -72.48 -27.02 16.26 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.193 1.929 . . . . 0.0 111.112 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 5.0 t -57.84 -35.63 71.18 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.523 -0.736 . . . . 0.0 109.437 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD2' HG13 ' B' ' 28' ' ' ILE . 1.8 ptpt -88.44 -22.54 23.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.624 -0.673 . . . . 0.0 110.0 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.2 mt -64.83 109.98 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.452 -0.78 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.555 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 17.4 mt-10 -100.74 -28.82 12.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.83 -0.544 . . . . 0.0 109.638 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 30.2 mttt -142.32 147.98 37.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.681 -0.637 . . . . 0.0 110.485 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 87.2 m -132.78 98.03 4.21 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 11.6 m-85 -94.58 153.9 17.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.713 -0.617 . . . . 0.0 109.686 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -143.9 132.59 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 1.8 ptm180 -68.13 115.1 7.22 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.708 -0.62 . . . . 0.0 110.038 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -124.77 109.63 13.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.741 -0.599 . . . . 0.0 109.512 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -109.32 -54.4 2.54 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.702 -0.624 . . . . 0.0 109.55 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -78.24 134.89 62.41 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -78.44 -70.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.778 2.319 . . . . 0.0 110.692 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.21 -57.59 0.42 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.61 -0.681 . . . . 0.0 109.739 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 29.3 p90 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.466 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 37' ' ' ILE . 54.4 mtp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 1.1 mttt -144.74 177.79 8.45 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.457 0.646 . . . . 0.0 109.577 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 3' ' ' ILE . 1.7 mp -91.28 105.35 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -85.04 -40.1 17.23 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.537 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -160.77 177.91 9.97 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.561 0.695 . . . . 0.0 110.114 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.748 HG23 ' CD1' ' A' ' 12' ' ' ILE . 3.7 mp -125.14 126.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.697 HD11 HD12 ' A' ' 22' ' ' ILE . 7.0 mt -97.85 -49.17 4.91 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 8.5 p30 -169.83 -169.97 0.96 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 33.7 t60 -53.66 -31.53 48.0 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.542 -0.724 . . . . 0.0 111.902 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.44 -27.08 8.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.213 -0.929 . . . . 0.0 111.699 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -97.16 130.95 44.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.138 -0.976 . . . . 0.0 110.187 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.748 ' CD1' HG23 ' A' ' 6' ' ' ILE . 40.0 mm -144.31 138.6 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 22' ' ' ILE . 7.8 t -84.57 130.72 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.616 HG21 HD22 ' A' ' 23' ' ' LEU . 29.0 m -129.04 146.84 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.635 -0.665 . . . . 0.0 109.963 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.64 167.0 10.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.7 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 19.6 t70 -163.13 164.27 25.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.817 -0.552 . . . . 0.0 109.701 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.19 -42.29 50.99 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.855 -0.528 . . . . 0.0 109.654 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 19' ' ' GLU . 39.7 m-80 -64.6 -53.23 51.0 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.118 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' OE1' HG22 ' A' ' 48' ' ' ILE . 2.6 pt-20 172.14 -166.27 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.637 -0.664 . . . . 0.0 109.695 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.77 140.96 40.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.694 -0.628 . . . . 0.0 109.524 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.551 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -141.8 137.91 31.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.717 -0.614 . . . . 0.0 109.784 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.697 HD12 HD11 ' A' ' 7' ' ' LEU . 28.0 mm -90.31 125.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -108.6 120.63 43.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 110.22 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 15.7 mt -108.85 119.27 39.05 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -152.8 124.85 1.68 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.36 103.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.861 -0.788 . . . . 0.0 110.465 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 9.48 61.06 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' CB ' ' A' ' 42' ' ' LYS . 1.7 tt -61.8 -38.52 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-N 118.664 1.232 . . . . 0.0 109.339 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -64.08 -39.58 94.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.445 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 30.4 t80 -70.43 143.86 51.68 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 67.75 27.9 7.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.738 -0.601 . . . . 0.0 109.796 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 1.6 mmtm -148.25 153.26 38.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.673 -0.642 . . . . 0.0 109.803 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 7.4 ptmt -153.8 176.02 12.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.533 -0.73 . . . . 0.0 109.991 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.95 132.89 55.3 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 110.307 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 71.75 9.08 6.22 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.23 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -97.48 -3.14 40.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.0 110.296 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 1' ' ' MET . 49.8 mt 66.32 148.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.626 -0.671 . . . . 0.0 109.838 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 23' ' ' LEU . 14.9 p -80.25 137.74 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.484 -0.76 . . . . 0.0 110.265 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 43' ' ' ILE . 20.0 t70 -72.96 130.53 84.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.866 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.3 Cg_endo -71.61 -36.49 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.412 2.075 . . . . 0.0 110.983 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -29.23 69.55 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' CB ' HG13 ' A' ' 28' ' ' ILE . 40.5 mttp -85.99 -28.11 24.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.854 -0.529 . . . . 0.0 109.955 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.866 HD12 ' HA ' ' A' ' 40' ' ' PRO . 71.7 mt -55.36 110.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.643 -0.66 . . . . 0.0 109.684 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 13.9 mt-10 -104.44 -29.01 10.99 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.23 134.26 18.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.6 -0.688 . . . . 0.0 109.84 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 23' ' ' LEU . 98.2 m -112.42 120.04 40.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.662 -0.649 . . . . 0.0 109.466 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 16.2 m-85 -114.92 149.14 37.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.849 -0.532 . . . . 0.0 109.829 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.551 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -142.59 135.25 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.616 ' HD2' ' CZ ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -67.08 125.64 26.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.729 . . . . 0.0 109.957 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.61 111.2 5.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.673 -0.642 . . . . 0.0 109.429 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.08 -58.65 2.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.653 -0.654 . . . . 0.0 109.679 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 p -136.53 148.52 64.16 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 121.79 -0.568 . . . . 0.0 109.749 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.71 -65.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.816 2.344 . . . . 0.0 110.604 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -106.77 -54.72 2.43 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.635 . . . . 0.0 109.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 118.411 -0.804 . . . . 0.0 109.72 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.648 ' O ' HG23 ' B' ' 37' ' ' ILE . 56.2 mtp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' ILE . 0.8 OUTLIER -144.63 178.43 7.98 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.488 -0.757 . . . . 0.0 109.713 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' B' ' 34' ' ' LYS . 7.8 mm -90.65 104.83 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.364 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' B' ' 15' ' ' LYS . 10.1 tmtt? -85.02 -40.31 17.02 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.0 OUTLIER -161.62 178.26 9.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.395 0.617 . . . . 0.0 110.188 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.755 HG23 ' CD1' ' B' ' 12' ' ' ILE . 3.7 mp -125.18 126.96 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.698 HD11 HD12 ' B' ' 22' ' ' ILE . 7.0 mt -97.96 -49.12 4.89 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 8.4 p30 -169.77 -170.14 0.99 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 33.9 t60 -53.5 -31.52 46.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.448 -0.783 . . . . 0.0 111.9 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -113.48 -27.29 7.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.165 -0.959 . . . . 0.0 111.637 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -97.04 131.01 44.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.105 -0.997 . . . . 0.0 110.153 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.755 ' CD1' HG23 ' B' ' 6' ' ' ILE . 40.1 mm -144.23 138.71 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' B' ' 22' ' ' ILE . 7.4 t -84.7 130.74 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.63 HG21 HD22 ' B' ' 23' ' ' LEU . 31.2 m -128.87 148.79 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 109.889 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 4' ' ' LYS . 0.8 OUTLIER -104.91 166.68 10.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.634 -0.667 . . . . 0.0 109.63 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.444 ' CB ' ' HD3' ' B' ' 21' ' ' LYS . 19.5 t70 -162.84 164.41 26.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.824 -0.548 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.32 -42.55 52.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.84 -0.538 . . . . 0.0 109.69 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' B' ' 19' ' ' GLU . 39.5 m-80 -64.13 -53.27 52.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.089 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.506 ' OE1' HG22 ' B' ' 48' ' ' ILE . 2.7 pt-20 173.28 -163.07 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.603 -0.685 . . . . 0.0 109.642 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -82.83 137.2 34.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.581 -0.7 . . . . 0.0 109.729 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.758 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -137.93 142.22 40.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.629 -0.67 . . . . 0.0 109.872 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.698 HD12 HD11 ' B' ' 7' ' ' LEU . 26.5 mm -91.65 126.06 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.891 ' CD2' HG11 ' B' ' 38' ' ' VAL . 0.9 OUTLIER -108.7 120.33 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.651 -0.656 . . . . 0.0 110.185 -179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.61 119.44 39.53 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -153.12 124.71 1.64 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.25 103.13 0.07 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.766 -0.843 . . . . 0.0 110.498 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.66 61.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.7 tt -62.12 -38.49 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 118.705 1.252 . . . . 0.0 109.28 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -64.0 -39.87 95.1 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 30.3 t80 -70.05 144.16 52.28 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 67.79 27.72 7.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.739 -0.601 . . . . 0.0 109.764 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 1.6 mmtm -147.94 152.73 38.03 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.461 ' O ' HG13 ' B' ' 3' ' ' ILE . 7.2 ptmt -154.23 169.54 23.38 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.538 -0.726 . . . . 0.0 109.956 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.477 ' HA ' ' HB ' ' B' ' 3' ' ' ILE . 21.4 tptm -54.82 131.96 45.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.523 0.677 . . . . 0.0 110.594 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' B' ' 2' ' ' LYS . 0.3 OUTLIER 72.62 9.12 5.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.262 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -97.07 -4.55 39.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.067 -1.02 . . . . 0.0 110.458 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . 0.648 HG23 ' O ' ' B' ' 1' ' ' MET . 50.9 mt 67.48 148.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 109.518 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' B' ' 23' ' ' LEU . 14.9 p -80.09 137.85 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 110.349 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.461 ' O ' HG13 ' B' ' 43' ' ' ILE . 19.6 t70 -72.77 130.16 85.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.842 ' HA ' HD12 ' B' ' 43' ' ' ILE . 32.0 Cg_endo -71.62 -36.44 6.55 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.424 2.082 . . . . 0.0 111.156 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.41 -28.12 69.03 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' B' ' 28' ' ' ILE . 15.0 mtmm -88.74 -24.73 22.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.784 -0.572 . . . . 0.0 109.987 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.842 HD12 ' HA ' ' B' ' 40' ' ' PRO . 65.7 mt -57.63 110.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.472 -0.768 . . . . 0.0 109.351 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.418 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 14.0 mt-10 -104.0 -28.79 11.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.27 134.71 18.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.693 -0.63 . . . . 0.0 109.889 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.447 ' HA ' HD12 ' B' ' 23' ' ' LEU . 98.1 m -112.97 119.48 38.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.708 -0.62 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 16.0 m-85 -114.41 148.74 37.26 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -141.97 135.24 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.602 ' HD2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -66.99 125.55 26.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.516 -0.74 . . . . 0.0 109.922 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -70.62 111.24 5.96 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.75 -0.594 . . . . 0.0 109.453 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.31 -58.37 2.87 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.658 -0.651 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 11.2 p -136.75 148.33 62.93 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.814 -0.554 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.61 -65.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.737 2.291 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.87 -54.75 2.42 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.76 -0.587 . . . . 0.0 109.455 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.685 ' HE3' HG11 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' HE3' ' HG3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -75.01 151.64 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.632 0.729 . . . . 0.0 109.888 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 36' ' ' ASP . 1.6 mp -77.72 111.51 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.652 . . . . 0.0 109.421 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -87.23 -38.43 16.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.677 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 86.1 mtm180 -145.33 167.25 23.32 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.28 0.562 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' CD1' ' A' ' 12' ' ' ILE . 23.3 mm -116.74 124.8 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 12' ' ' ILE . 8.8 mt -93.29 -48.59 6.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.4 p30 -170.91 -166.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 43.2 t60 -58.33 -30.2 66.53 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.244 -0.91 . . . . 0.0 111.621 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -112.16 -26.88 8.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 111.587 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 7' ' ' LEU . . . -99.63 133.14 44.39 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.174 -0.954 . . . . 0.0 110.445 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 29' ' ' ALA . 31.9 mm -144.69 137.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 7.6 t -87.42 111.01 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 23' ' ' LEU . 32.3 m -109.59 169.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 109.442 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 4.2 pttp -143.02 155.57 44.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 109.858 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.35 -176.6 5.0 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.295 0.569 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -43.8 76.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.713 -0.617 . . . . 0.0 109.994 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -62.64 -53.99 46.24 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.191 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.5 -175.23 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.679 -0.638 . . . . 0.0 109.832 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 30.7 tt0 -75.83 148.77 38.12 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HB3' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -146.33 132.01 18.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 0.0 109.704 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' B' ' 22' ' ' ILE . 29.3 mm -80.62 124.81 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD23 HG21 ' A' ' 38' ' ' VAL . 1.2 mp -110.01 125.91 53.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.607 -0.683 . . . . 0.0 110.203 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD11 HD11 ' B' ' 22' ' ' ILE . 9.0 mt -117.27 108.36 15.54 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -142.85 126.67 2.92 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.4 102.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.833 -0.804 . . . . 0.0 110.496 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.53 10.53 60.39 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.3 tt -61.79 -38.95 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 118.638 1.219 . . . . 0.0 109.349 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -63.17 -38.85 92.81 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 72.5 t80 -69.49 145.47 52.68 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.34 25.26 3.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.936 -0.478 . . . . 0.0 110.078 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.1 164.81 13.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.555 -0.716 . . . . 0.0 109.92 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.41 178.83 9.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.402 -0.811 . . . . 0.0 110.173 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 1.5 tttm -60.3 137.11 58.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.655 -0.653 . . . . 0.0 110.121 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER 85.98 -21.94 0.2 Allowed 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.399 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.625 ' O ' HD12 ' A' ' 3' ' ' ILE . 7.3 t70 -83.02 156.23 23.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.953 . . . . 0.0 109.143 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.3 mm -76.58 147.12 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.498 -0.752 . . . . 0.0 109.094 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.812 HG21 HD23 ' A' ' 23' ' ' LEU . 14.8 p -77.34 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.694 -0.629 . . . . 0.0 109.991 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' O ' HG13 ' A' ' 43' ' ' ILE . 21.4 t70 -72.63 125.88 91.03 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.644 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.2 Cg_endo -71.05 -36.68 7.09 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.383 2.055 . . . . 0.0 110.901 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.18 69.38 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -85.47 -25.69 26.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.878 -0.514 . . . . 0.0 109.888 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 40' ' ' PRO . 84.4 mt -56.42 108.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.501 -0.749 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 16.1 mt-10 -105.15 -28.45 10.98 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -142.91 129.93 20.68 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.661 -0.649 . . . . 0.0 109.884 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.8 m -112.22 109.03 18.48 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 29.0 m-85 -109.28 140.46 42.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.745 -0.597 . . . . 0.0 109.827 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -140.52 143.44 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 46' ' ' THR . 70.2 mtm180 -57.84 107.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.692 . . . . 0.0 109.208 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HE2' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -94.62 125.27 39.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.712 -0.618 . . . . 0.0 110.051 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -111.84 -58.13 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 3.3 p -141.03 127.87 11.75 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 50' ' ' LYS . 35.2 Cg_endo -77.77 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.71 2.273 . . . . 0.0 110.835 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' B' ' 54' ' ' ASP . 0.4 OUTLIER -80.26 -26.02 39.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.526 -0.734 . . . . 0.0 110.129 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 52' ' ' THR . 36.6 m-85 . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.83 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.26 0.552 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.461 ' HE3' ' HG3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -78.04 151.07 33.69 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.572 0.701 . . . . 0.0 109.765 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.632 HD12 ' O ' ' B' ' 36' ' ' ASP . 1.7 mp -77.13 111.29 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.431 0.634 . . . . 0.0 109.504 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.413 ' HG3' ' HD3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -87.34 -38.51 16.16 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 86.1 mtm180 -145.28 167.28 23.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.806 -0.559 . . . . 0.0 109.902 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.675 HG23 ' CD1' ' B' ' 12' ' ' ILE . 22.7 mm -116.76 124.89 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.689 -0.632 . . . . 0.0 109.362 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' ' 12' ' ' ILE . 8.8 mt -93.45 -48.61 6.31 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.9 p30 -170.84 -166.49 0.49 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 43.2 t60 -58.69 -30.21 67.22 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.231 -0.918 . . . . 0.0 111.653 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -112.18 -26.75 8.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.296 -0.877 . . . . 0.0 111.595 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' B' ' 7' ' ' LEU . . . -99.66 133.21 44.32 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.242 -0.911 . . . . 0.0 110.419 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 29' ' ' ALA . 32.1 mm -144.74 137.02 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 7.2 t -87.42 110.85 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.479 HG21 HD22 ' B' ' 23' ' ' LEU . 32.8 m -109.47 169.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.701 . . . . 0.0 109.443 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' B' ' 20' ' ' GLU . 4.0 pttp -142.89 154.56 44.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.522 -0.736 . . . . 0.0 109.898 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.87 -176.62 4.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.823 -0.548 . . . . 0.0 109.744 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.61 77.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.782 -0.573 . . . . 0.0 110.033 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -62.71 -53.9 47.45 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.178 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 175.58 -175.26 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' B' ' 15' ' ' LYS . 30.6 tt0 -75.75 148.8 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.642 -0.661 . . . . 0.0 109.732 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.509 ' HB3' HG23 ' B' ' 48' ' ' ILE . 0.0 OUTLIER -146.38 131.91 18.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.0 109.693 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 22' ' ' ILE . 29.3 mm -80.51 125.09 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.816 HD23 HG21 ' B' ' 38' ' ' VAL . 1.2 mp -110.14 125.97 53.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.582 -0.699 . . . . 0.0 110.191 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.654 HD11 HD11 ' A' ' 22' ' ' ILE . 9.0 mt -117.48 108.35 15.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -142.94 126.7 2.92 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.48 102.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.721 0.772 . . . . 0.0 110.546 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.54 10.52 60.39 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.476 HD12 ' HA3' ' B' ' 25' ' ' GLY . 1.3 tt -61.78 -38.94 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.162 -1.199 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' B' ' 12' ' ' ILE . . . -63.2 -38.74 92.36 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 72.5 t80 -69.56 145.54 52.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 71.2 25.36 3.62 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.809 -0.557 . . . . 0.0 110.18 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -168.16 164.87 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.008 179.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 178.81 9.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.428 -0.795 . . . . 0.0 110.137 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 1.6 tttm -60.32 137.1 58.19 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.688 -0.632 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 0.1 OUTLIER 85.99 -22.11 0.19 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.377 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.632 ' O ' HD12 ' B' ' 3' ' ' ILE . 7.4 t70 -82.78 156.36 23.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 109.173 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -76.75 146.93 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.138 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 HD23 ' B' ' 23' ' ' LEU . 13.5 p -77.27 141.6 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.695 -0.628 . . . . 0.0 109.969 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.495 ' O ' HG13 ' B' ' 43' ' ' ILE . 21.2 t70 -72.17 125.43 91.46 Favored Pre-proline 0 N--CA 1.487 1.403 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.634 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -70.95 -36.45 7.63 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.368 2.046 . . . . 0.0 110.813 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.06 -28.4 69.57 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -85.02 -25.5 27.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.9 -0.5 . . . . 0.0 109.922 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.634 HD12 ' HA ' ' B' ' 40' ' ' PRO . 83.9 mt -56.46 109.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 16.3 mt-10 -105.16 -28.52 10.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 1.0 OUTLIER -142.94 129.88 20.59 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.744 -0.597 . . . . 0.0 109.896 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' ARG . 90.2 m -112.15 109.19 18.75 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 29.1 m-85 -109.28 140.52 42.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.746 -0.596 . . . . 0.0 109.852 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' B' ' 21' ' ' LYS . 0.1 OUTLIER -140.51 143.49 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 -57.88 107.74 0.5 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.646 -0.659 . . . . 0.0 109.26 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . 0.416 ' HE2' ' HD3' ' B' ' 53' ' ' PRO . 0.7 OUTLIER -94.59 125.16 39.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.655 -0.653 . . . . 0.0 110.118 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.71 -58.26 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.596 ' HB ' ' HB2' ' B' ' 55' ' ' TYR . 3.3 p -140.98 127.83 11.78 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.416 ' HD3' ' HE2' ' B' ' 50' ' ' LYS . 35.1 Cg_endo -77.71 -80.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.749 2.299 . . . . 0.0 110.875 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -80.21 -26.02 39.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.458 -0.776 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' B' ' 52' ' ' THR . 36.8 m-85 . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.409 -0.807 . . . . 0.0 109.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HE1' HD11 ' A' ' 43' ' ' ILE . 24.9 mtp . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.44 0.638 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 171.59 9.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.651 0.739 . . . . 0.0 109.961 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 14' ' ' VAL . 2.3 mp -103.01 118.94 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.481 0.658 . . . . 0.0 109.842 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 1.9 ttmt -86.23 -36.25 19.53 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 6.9 mtm180 -146.09 167.78 22.57 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.372 0.606 . . . . 0.0 110.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 34' ' ' LYS . 4.3 mp -123.06 127.42 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' B' ' 11' ' ' ALA . 8.3 mt -93.08 -47.36 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 11' ' ' ALA . 11.8 p30 -170.28 -165.73 0.48 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 30' ' ' PHE . 51.4 t60 -60.72 -24.36 65.61 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.234 -0.916 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -116.88 -28.58 6.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 111.502 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -100.85 139.07 37.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.257 -0.902 . . . . 0.0 110.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -151.52 148.76 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 5' ' ' ARG . 6.0 t -97.35 115.77 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG12 HG13 ' A' ' 3' ' ' ILE . 34.2 m -116.7 172.98 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.681 -0.637 . . . . 0.0 109.73 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 6.6 ptpt -123.93 160.72 26.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.54 -0.725 . . . . 0.0 109.729 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.84 -174.88 5.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.749 -0.594 . . . . 0.0 110.059 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -45.4 86.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.855 -0.528 . . . . 0.0 109.916 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.79 -55.55 19.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 120.411 -0.515 . . . . 0.0 109.962 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.2 -154.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.679 -0.638 . . . . 0.0 109.686 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -76.47 145.4 39.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.512 -0.742 . . . . 0.0 110.336 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HB3' HG23 ' A' ' 48' ' ' ILE . 3.0 ptpt -151.72 137.49 17.98 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 13' ' ' VAL . 1.5 mp -88.92 121.0 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.769 HD23 HG21 ' A' ' 38' ' ' VAL . 1.1 tp -96.15 109.55 21.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.788 -0.57 . . . . 0.0 109.692 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 mt -94.75 127.23 40.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -162.06 120.36 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.52 102.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.799 . . . . 0.0 110.198 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.1 55.17 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.565 HG23 HD13 ' A' ' 12' ' ' ILE . 1.3 tt -62.01 -39.88 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 1.182 . . . . 0.0 109.186 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 12' ' ' ILE . . . -59.21 -35.85 74.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' HB2' ' CE1' ' A' ' 9' ' ' HIS . 28.4 t80 -72.84 147.27 45.6 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 30' ' ' PHE . 3.3 t-20 76.52 20.04 1.52 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.056 -0.402 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.674 ' HD2' ' HA ' ' A' ' 38' ' ' VAL . 4.2 ptmm? 179.53 -179.07 0.4 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.477 -0.765 . . . . 0.0 109.981 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.5 -172.15 3.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.385 -0.822 . . . . 0.0 110.013 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.617 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.7 tttt -65.02 136.82 57.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.484 -0.76 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 2.1 t-20 85.95 -23.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.143 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.31 172.2 13.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.341 -0.849 . . . . 0.0 109.108 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.67 145.68 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 109.08 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.769 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -75.16 135.04 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.749 -0.594 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 43' ' ' ILE . 15.7 t70 -66.6 122.06 80.2 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.7 Cg_endo -71.68 -36.16 6.82 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.41 2.074 . . . . 0.0 111.077 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.68 -29.24 69.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HB2' HG13 ' A' ' 28' ' ' ILE . 6.7 mmtm -86.98 -26.9 23.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.828 -0.545 . . . . 0.0 110.224 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 40' ' ' PRO . 76.4 mt -51.48 108.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -104.0 -30.56 10.21 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -159.6 143.22 14.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.514 -0.741 . . . . 0.0 110.202 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.2 m -113.69 113.95 25.72 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 17.0 m-85 -103.41 135.55 44.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.672 -0.642 . . . . 0.0 109.803 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.518 ' HB ' ' HD2' ' B' ' 50' ' ' LYS . 0.3 OUTLIER -131.88 137.82 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -61.75 112.43 2.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.58 -0.7 . . . . 0.0 109.72 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.547 ' HD2' ' HB ' ' B' ' 48' ' ' ILE . 9.2 mttt -88.02 107.07 18.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.679 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.75 -55.45 3.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.707 -0.621 . . . . 0.0 109.43 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 55' ' ' TYR . 38.8 p 43.63 79.65 0.32 Allowed Pre-proline 0 N--CA 1.503 2.223 0 CA-C-O 120.78 0.324 . . . . 0.0 110.62 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.77 -37.54 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 123.28 2.653 . . . . 0.0 110.939 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -12.89 52.68 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 122.061 -0.399 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 117.617 -1.182 . . . . 0.0 111.045 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.405 ' HE1' HD11 ' B' ' 43' ' ' ILE . 25.4 mtp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.44 0.638 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.52 171.36 9.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.586 0.708 . . . . 0.0 109.956 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.525 HG12 HG21 ' B' ' 12' ' ' ILE . 2.2 mp -102.43 119.33 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.405 0.621 . . . . 0.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 1.9 ttmt -86.75 -36.4 18.65 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.713 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 6.9 mtm180 -146.13 167.22 23.95 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.325 0.583 . . . . 0.0 109.88 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.798 HG23 ' CD1' ' B' ' 12' ' ' ILE . 4.3 mp -122.2 127.05 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' A' ' 11' ' ' ALA . 8.5 mt -92.56 -47.78 6.95 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 11' ' ' ALA . 11.5 p30 -170.45 -165.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' B' ' 30' ' ' PHE . 50.1 t60 -60.53 -24.0 65.01 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.29 -0.881 . . . . 0.0 111.751 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -117.43 -28.5 6.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.0 111.553 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.597 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.68 135.9 40.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.124 -0.985 . . . . 0.0 110.448 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' B' ' 6' ' ' ILE . 26.1 mm -145.41 147.22 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.713 ' HB ' ' HB2' ' B' ' 5' ' ' ARG . 9.6 t -98.25 113.74 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.514 HG12 HG13 ' B' ' 3' ' ' ILE . 29.5 m -115.67 173.82 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.615 -0.678 . . . . 0.0 109.977 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' B' ' 4' ' ' LYS . 6.7 ptpt -124.68 160.82 27.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.691 -0.63 . . . . 0.0 109.606 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.08 -174.89 5.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.731 -0.606 . . . . 0.0 110.072 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -45.47 85.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.738 -0.601 . . . . 0.0 109.825 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -64.78 -55.54 19.12 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.911 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.22 -154.77 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.693 -0.629 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -76.36 145.51 39.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.325 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' B' ' 48' ' ' ILE . 3.1 ptpt -151.78 137.63 18.04 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.483 HG13 HG22 ' B' ' 13' ' ' VAL . 1.5 mp -89.11 120.72 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.746 HD23 HG21 ' B' ' 38' ' ' VAL . 1.1 tp -95.96 109.59 21.94 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.332 0.586 . . . . 0.0 109.727 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 46.0 mt -94.76 128.19 41.29 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.413 ' HA3' HD12 ' B' ' 28' ' ' ILE . . . -163.26 120.12 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.32 102.44 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.878 -0.778 . . . . 0.0 110.241 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.05 10.8 55.85 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' B' ' 42' ' ' LYS . 1.5 tt -61.87 -39.88 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 118.562 1.181 . . . . 0.0 109.24 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -59.34 -35.55 74.06 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' B' ' 9' ' ' HIS . 28.6 t80 -72.9 147.45 45.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' B' ' 30' ' ' PHE . 3.3 t-20 76.44 19.97 1.57 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.001 -0.437 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.673 ' HD2' ' HA ' ' B' ' 38' ' ' VAL . 4.0 ptmm? 179.68 -179.25 0.43 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.348 -0.845 . . . . 0.0 109.916 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.28 -172.13 3.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.402 -0.811 . . . . 0.0 110.059 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' B' ' 6' ' ' ILE . 3.8 tttt -64.92 136.87 57.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.494 -0.754 . . . . 0.0 109.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 2.1 t-20 85.75 -23.2 0.16 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.133 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.8 171.86 14.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.104 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 mm -81.23 145.57 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.746 HG21 HD23 ' B' ' 23' ' ' LEU . 11.2 p -75.14 135.12 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.585 . . . . 0.0 109.887 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.465 ' O ' HG13 ' B' ' 43' ' ' ILE . 15.7 t70 -66.6 122.17 80.71 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.718 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.9 Cg_endo -71.73 -36.19 6.69 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.44 2.093 . . . . 0.0 111.085 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -60.7 -29.18 69.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.518 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.7 mmtm -87.04 -26.97 23.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.589 . . . . 0.0 110.208 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' B' ' 40' ' ' PRO . 76.8 mt -51.46 108.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 O-C-N 121.506 -0.746 . . . . 0.0 109.545 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.93 -30.5 10.27 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -159.68 143.38 14.51 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 110.248 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -113.73 114.01 25.77 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.656 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 17.0 m-85 -103.36 135.63 44.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.766 -0.584 . . . . 0.0 109.807 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.547 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -132.01 137.8 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -61.69 112.39 2.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . 0.518 ' HD2' ' HB ' ' A' ' 48' ' ' ILE . 9.4 mttt -87.95 107.05 18.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.754 . . . . 0.0 109.717 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.74 -55.44 3.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.662 -0.648 . . . . 0.0 109.456 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' B' ' 55' ' ' TYR . 39.1 p 43.69 79.59 0.33 Allowed Pre-proline 0 N--CA 1.505 2.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.55 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -81.78 -37.47 0.26 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.251 2.634 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.88 -12.8 52.85 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.919 -0.488 . . . . 0.0 111.154 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' B' ' 52' ' ' THR . 4.1 p90 . . . . . 0 N--CA 1.501 2.09 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.024 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG12 ' A' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.534 0.683 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -83.81 166.17 18.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.615 0.721 . . . . 0.0 109.851 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG12 HD12 ' A' ' 12' ' ' ILE . 70.9 mt -94.81 102.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.96 60.6 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.703 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 0.9 OUTLIER -143.32 167.55 21.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.376 0.608 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 12' ' ' ILE . 3.7 mp -123.9 118.8 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' B' ' 11' ' ' ALA . 13.5 mt -81.46 -47.3 13.36 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -163.51 -154.45 0.28 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -78.7 -5.48 53.23 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.896 -1.127 . . . . 0.0 111.073 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -126.68 -35.9 2.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 110.951 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' B' ' 7' ' ' LEU . . . -99.84 141.09 33.12 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.358 -0.839 . . . . 0.0 110.577 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 6' ' ' ILE . 3.5 pt -150.44 144.74 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 22' ' ' ILE . 21.2 t -89.82 114.16 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 21' ' ' LYS . 33.8 m -111.33 175.41 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.618 -0.676 . . . . 0.0 109.944 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -120.96 147.62 45.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.75 179.21 6.61 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.314 0.578 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.21 -42.85 82.08 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.817 -0.552 . . . . 0.0 109.916 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -61.92 -52.86 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.187 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.37 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 0.0 109.321 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -131.65 139.64 49.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.68 -0.637 . . . . 0.0 109.482 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.867 ' HG2' HG23 ' A' ' 48' ' ' ILE . 32.2 mttt -124.33 171.86 9.57 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.5 0.667 . . . . 0.0 109.767 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 13' ' ' VAL . 12.8 mm -129.45 120.84 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.902 ' HG ' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -98.76 112.01 24.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.444 -0.785 . . . . 0.0 109.903 -179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 17.8 mt -107.61 90.92 3.45 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' A' ' 44' ' ' GLU . . . -131.15 123.17 3.7 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.43 100.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.918 -0.754 . . . . 0.0 110.595 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.08 6.6 53.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -61.44 -38.92 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 118.524 1.162 . . . . 0.0 109.362 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 9' ' ' HIS . . . -61.75 -38.61 88.61 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -68.38 140.46 55.84 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.77 30.59 2.3 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.274 0.559 . . . . 0.0 109.583 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HG2' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -167.24 168.01 13.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.67 -0.644 . . . . 0.0 109.705 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -155.5 175.52 13.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.343 -0.848 . . . . 0.0 110.408 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 4.1 tmtm? -59.27 132.32 53.65 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.667 -0.646 . . . . 0.0 109.912 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 34' ' ' LYS . 5.0 t-20 85.76 -15.12 0.51 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.561 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.54 25.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 109.193 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.33 145.82 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.902 HG21 ' HG ' ' A' ' 23' ' ' LEU . 14.4 p -74.95 138.41 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' O ' HG13 ' A' ' 43' ' ' ILE . 13.2 t70 -69.98 126.01 92.25 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HA ' HD12 ' A' ' 43' ' ' ILE . 31.5 Cg_endo -71.14 -37.45 6.0 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.412 2.075 . . . . 0.0 110.972 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 t -62.8 -27.93 69.65 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.75 -20.12 26.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.83 -0.544 . . . . 0.0 110.093 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.824 HG23 HD11 ' A' ' 23' ' ' LEU . 62.0 mt -57.3 108.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.428 -0.795 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.567 ' HB2' ' HA2' ' A' ' 25' ' ' GLY . 12.8 mt-10 -105.84 -30.97 9.05 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 24' ' ' LEU . 7.7 mttt -148.62 124.57 10.64 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.756 -0.59 . . . . 0.0 109.76 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.8 m -107.47 116.08 31.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.668 -0.645 . . . . 0.0 109.409 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 10.5 m-85 -110.2 150.19 29.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.798 -0.564 . . . . 0.0 109.983 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.867 HG23 ' HG2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -132.77 139.11 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.822 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.566 ' HB2' ' CZ ' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -72.42 123.25 22.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.657 -0.652 . . . . 0.0 109.639 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -68.42 101.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -88.79 -48.52 7.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.648 -0.657 . . . . 0.0 109.652 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 p -74.65 120.91 83.8 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 109.725 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HD2' ' CE2' ' A' ' 55' ' ' TYR . 35.1 Cg_endo -78.12 -63.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.768 2.312 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -122.99 -53.56 1.84 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.74 -0.6 . . . . 0.0 109.739 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 53' ' ' PRO . 49.1 p90 . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.502 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.499 ' HB3' HG12 ' B' ' 38' ' ' VAL . 3.1 mtp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.537 0.684 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -83.85 166.11 18.2 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.635 0.731 . . . . 0.0 109.92 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.516 HD12 ' O ' ' B' ' 33' ' ' LYS . 70.6 mt -94.76 102.5 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.05 -39.85 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.686 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 0.9 OUTLIER -143.37 167.42 22.22 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.373 0.606 . . . . 0.0 110.014 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' B' ' 12' ' ' ILE . 3.7 mp -123.74 118.77 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.688 HD22 ' HB2' ' A' ' 11' ' ' ALA . 15.6 mt -81.47 -47.18 13.51 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -163.67 -154.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.556 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -78.96 -5.82 54.75 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.906 -1.121 . . . . 0.0 111.036 -179.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.46 -35.6 2.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.308 -0.87 . . . . 0.0 110.957 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -99.76 141.06 33.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' B' ' 6' ' ' ILE . 3.6 pt -150.61 144.8 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.85 ' HA ' HD13 ' B' ' 22' ' ' ILE . 21.0 t -90.03 114.06 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' B' ' 21' ' ' LYS . 33.9 m -111.16 175.45 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.003 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -121.0 147.58 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.651 -0.655 . . . . 0.0 109.282 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.73 179.3 6.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.38 0.61 . . . . 0.0 110.065 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.33 -42.77 82.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.852 -0.53 . . . . 0.0 109.877 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -62.01 -52.72 62.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 179.27 -92.65 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.626 -0.671 . . . . 0.0 109.29 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -131.57 139.54 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.878 ' HG2' HG23 ' B' ' 48' ' ' ILE . 32.1 mttt -124.22 171.84 9.53 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.486 0.66 . . . . 0.0 109.822 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' B' ' 13' ' ' VAL . 13.1 mm -129.43 120.84 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.908 ' HG ' HG21 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -98.72 112.13 24.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.934 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' HB2' ' B' ' 45' ' ' LYS . 17.6 mt -107.68 90.52 3.32 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' B' ' 44' ' ' GLU . . . -130.64 123.3 3.85 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.1 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.865 -0.785 . . . . 0.0 110.592 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.58 5.66 55.35 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.468 HG21 HG12 ' B' ' 12' ' ' ILE . 0.6 OUTLIER -59.89 -38.69 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-N 118.554 1.177 . . . . 0.0 109.488 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' B' ' 9' ' ' HIS . . . -61.55 -39.09 89.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -68.02 140.56 56.34 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 71.72 30.41 2.36 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.351 0.596 . . . . 0.0 109.596 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.476 ' HG2' HD11 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -167.14 168.09 13.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.613 -0.679 . . . . 0.0 109.675 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.516 ' O ' HD12 ' B' ' 3' ' ' ILE . 0.0 OUTLIER -155.54 175.38 13.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 0.0 110.456 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 4.1 tmtm? -59.09 132.23 53.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.676 -0.64 . . . . 0.0 109.962 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' B' ' 34' ' ' LYS . 5.0 t-20 85.84 -15.2 0.5 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.527 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -84.32 149.51 26.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 29.5 mm -68.37 145.67 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.908 HG21 ' HG ' ' B' ' 23' ' ' LEU . 14.4 p -74.86 138.21 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.424 0.63 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.494 ' O ' HG13 ' B' ' 43' ' ' ILE . 12.4 t70 -69.86 126.23 92.39 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' PRO . . . . . 0.656 ' HA ' HD12 ' B' ' 43' ' ' ILE . 31.2 Cg_endo -71.15 -36.98 6.5 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.362 2.041 . . . . 0.0 110.907 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -62.59 -29.77 70.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HB2' HG13 ' B' ' 28' ' ' ILE . 25.5 mmmt -85.32 -21.75 28.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.827 -0.545 . . . . 0.0 110.134 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.807 HG23 HD11 ' B' ' 23' ' ' LEU . 62.9 mt -55.93 108.7 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.768 . . . . 0.0 109.548 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLU . . . . . 0.571 ' HB2' ' HA2' ' B' ' 25' ' ' GLY . 12.7 mt-10 -106.03 -31.19 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' B' ' 24' ' ' LEU . 7.6 mttt -148.48 124.42 10.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.711 -0.618 . . . . 0.0 109.809 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -107.28 116.26 31.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 10.5 m-85 -110.35 150.2 29.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 110.014 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.878 HG23 ' HG2' ' B' ' 21' ' ' LYS . 0.3 OUTLIER -132.78 139.28 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.761 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -72.63 123.28 22.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.566 -0.709 . . . . 0.0 109.685 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -68.39 101.6 1.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -88.81 -48.44 7.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.659 -0.651 . . . . 0.0 109.672 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 10.9 p -74.79 120.91 83.83 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.811 -0.556 . . . . 0.0 109.674 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' B' ' 55' ' ' TYR . 35.1 Cg_endo -78.11 -63.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.809 2.339 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.07 -53.43 1.84 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 0.0 109.729 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' B' ' 53' ' ' PRO . 48.9 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.495 -179.947 . . . . . . . . 1 1 . 1 stop_ save_